ulcerative colitis
Information
- Disease name
- ulcerative colitis
- Disease ID
- DOID:8577
- Description
- "A colitis that is predominantly confined to the mucosa located_in colon and includes characteristic ulcers, or open sores." [url:http\://en.wikipedia.org/wiki/Ulcerative_colitis, url:https\://meshb.nlm.nih.gov/record/ui?ui=D003093]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04033445 | Active, not recruiting | Phase 2/Phase 3 | A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis | September 26, 2019 | October 27, 2027 |
| NCT04798625 | Active, not recruiting | Vaccine Response to COVID-19 Vaccines in Patients Using Immunosuppressive Medication | February 15, 2021 | February 15, 2027 | |
| NCT04520594 | Active, not recruiting | N/A | OptiMized REsistaNt Starch in Inflammatory Bowel Disease: The MEND Trial | March 3, 2021 | August 1, 2024 |
| NCT03798691 | Active, not recruiting | Phase 4 | Immunogenicity of Herpes Zoster Subunit Vaccine in Inflammatory Bowel Disease Patients Treated With Vedolizumab | May 28, 2019 | September 2024 |
| NCT06113913 | Active, not recruiting | Phase 4 | Subcutaneous Infliximab After A Previous Intravenous Dose Optimization | April 9, 2024 | November 2026 |
| NCT03863704 | Active, not recruiting | N/A | Transcutaneous VNS to Treat Pediatric IBD | February 14, 2019 | December 31, 2023 |
| NCT04857112 | Active, not recruiting | Phase 2 | Study Evaluating Efficacy and Safety of Amiselimod (MT-1303) in Mild to Moderate Ulcerative Colitis | September 29, 2021 | September 2024 |
| NCT03549988 | Active, not recruiting | Pro-active Fecal Calprotectin Monitoring PROMOTE-UC | December 1, 2018 | December 31, 2025 | |
| NCT03524092 | Active, not recruiting | Phase 3 | A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis | October 19, 2018 | December 20, 2024 |
| NCT02291523 | Active, not recruiting | Phase 1 | The Effect of Therapeutic Fecal Transplant on the Gut Microbiome in Children With Ulcerative Colitis | November 1, 2016 | November 2023 |
| NCT04522271 | Active, not recruiting | N/A | Resistant Starch in Pediatric Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis) | August 25, 2020 | May 1, 2024 |
| NCT03196427 | Active, not recruiting | Phase 2 | Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) | July 30, 2018 | November 24, 2025 |
| NCT03441893 | Active, not recruiting | Phase 1/Phase 2 | Role of Intestinal Protozoa and Helminths in the Course of Ulcerative Colitis | January 1, 2015 | December 31, 2025 |
| NCT04996797 | Active, not recruiting | Phase 2 | A Phase 2 Safety and Efficacy Study of PRA023 in Subjects With Moderately to Severely Active Ulcerative Colitis | July 28, 2021 | June 30, 2026 |
| NCT05177835 | Active, not recruiting | Phase 2 | Long-term Safety and Efficacy Profile of ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis | December 3, 2021 | April 2027 |
| NCT04522843 | Active, not recruiting | Analysis of Intestinal Defensin Expression in Acute GVHD | September 1, 2018 | December 31, 2024 | |
| NCT05221281 | Active, not recruiting | N/A | Implementing a Multimodal RCT Intervention to Improve the Transition of Patients With Crohn's Disease From Pediatric to Adult Care | February 25, 2022 | December 31, 2025 |
| NCT05896943 | Active, not recruiting | The Application of Transcriptomics in the Treatment of Ulcerative Colitis With Ustekinumab | April 1, 2022 | June 30, 2024 | |
| NCT05384080 | Active, not recruiting | A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Poland | August 8, 2022 | August 31, 2025 | |
| NCT04621006 | Active, not recruiting | The Contact Activation System and Ulcerative Colitis | May 1, 2021 | August 27, 2024 | |
| NCT02721719 | Active, not recruiting | The Role of CD4+ T Cell Subsets in the Mechanism of Action of Vedolizumab in Ulcerative Colitis | May 2016 | December 2024 | |
| NCT03000101 | Active, not recruiting | N/A | Study of the Role of Pomegranate Juice Ellagitannins in the Modulation of Inflammation in Inflammatory Bowel Disease | January 19, 2017 | December 29, 2023 |
| NCT00606346 | Active, not recruiting | A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease | May 31, 2007 | June 30, 2038 | |
| NCT06353828 | Active, not recruiting | Phase 2 | Phase 2a Study to Evaluate IcBD-01 Enema in Active Ulcerative Colitis Patients | March 1, 2023 | April 1, 2025 |
| NCT04200690 | Active, not recruiting | N/A | Effectiveness of Interdisciplinary Care Compared to Usual Care in Patients With Immune-Mediated Inflammatory Diseases | January 14, 2020 | January 31, 2024 |
| NCT05463900 | Active, not recruiting | Microbial and Human Determinants of the Onset of IBD Flares | August 1, 2022 | July 2025 | |
| NCT02632175 | Active, not recruiting | Phase 3 | Long-term Safety and Efficacy Study of Adalimumab in Pediatric Subjects With Ulcerative Colitis | November 26, 2015 | May 14, 2025 |
| NCT01765439 | Active, not recruiting | N/A | The Effect of VSL#3 Probiotic Preparation on the Bile Acid Metabolism in Patients With Inflammatory Bowel Disease | February 2014 | March 2025 |
| NCT03162432 | Active, not recruiting | Phase 3 | High Dose Interval Vitamin D Supplementation in Patients With IBD Receiving Remicade | August 1, 2017 | December 1, 2023 |
| NCT03397108 | Active, not recruiting | Assessing the Drug Exposure Risk of Infants Breastfed by Women With Inflammatory Bowel Disease | July 4, 2017 | November 30, 2024 | |
| NCT02808780 | Active, not recruiting | An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis | December 16, 2016 | December 10, 2026 | |
| NCT03765450 | Active, not recruiting | Pharmacokinetics of IFX and TNF Concentrations in Serum, Stool, and Colonic Mucosa in Acute Severe Ulcerative Colitis | December 21, 2018 | December 2024 | |
| NCT04013152 | Active, not recruiting | Clinical Database of Colorectal Robotic Surgery | June 13, 2018 | June 9, 2027 | |
| NCT02531126 | Active, not recruiting | Phase 3 | An Extension Study of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis | December 2, 2015 | February 27, 2025 |
| NCT02914535 | Active, not recruiting | Phase 3 | Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis | February 23, 2017 | September 2026 |
| NCT03824561 | Active, not recruiting | Specified Drug-Use Survey on Vedolizumab for IV Infusion 300 mg [Ulcerative Colitis] | February 1, 2019 | October 31, 2024 | |
| NCT03518086 | Active, not recruiting | Phase 3 | An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1) | June 18, 2018 | May 2024 |
| NCT06031038 | Active, not recruiting | N/A | Impact of Telemonitoring in the Management of Complex IBD in Spain: M-TECCU | July 1, 2020 | April 30, 2024 |
| NCT06221995 | Active, not recruiting | Energy Expenditure in Patients With Ulcerative Colitis Undergoing Surgery | September 25, 2023 | December 25, 2025 | |
| NCT05788549 | Active, not recruiting | N/A | Assessment of the Effectiveness of Progressive Relaxation Techniques in Individuals With Ulcerative Colitis | February 1, 2022 | May 31, 2023 |
| NCT05549323 | Active, not recruiting | Phase 1 | A Study to Learn About the Safety, Effects and Pharmacokinetics of Study Medication (PF-07054894) for the Treatment of Ulcerative Colitis | November 7, 2022 | July 12, 2024 |
| NCT04583358 | Active, not recruiting | Phase 2 | Study of the Efficacy and Safety of AMT-101 in Subjects With Ulcerative Colitis (LOMBARD) | August 26, 2020 | December 31, 2022 |
| NCT04607837 | Active, not recruiting | Phase 2 | Etrasimod Versus Placebo for the Treatment of Moderately Active Ulcerative Colitis | April 12, 2021 | July 18, 2024 |
| NCT06013696 | Active, not recruiting | N/A | Bleach and Urine Color in UC Patients Using 5ASA | July 16, 2023 | December 2024 |
| NCT03266484 | Active, not recruiting | N/A | Effect of a Probiotic Mixture on the Gut Microbiome and Fatigue in Patients With Quiescent Inflammatory Bowel Disease | November 13, 2017 | July 2024 |
| NCT05653791 | Active, not recruiting | Early Intestinal Ultrasound in Predicting Treatment Response to Filgotinib in Ulcerative Colitis | October 1, 2022 | October 1, 2024 | |
| NCT00385736 | Completed | Phase 3 | Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute Ulcerative Colitis | November 2006 | March 2010 |
| NCT06281704 | Completed | Phase 1 | A Study of AK101 in Subjects With Moderately to Severely Active Ulcerative Colitis | November 26, 2020 | December 31, 2022 |
| NCT00403923 | Completed | Amount of Lactose Causing Symptoms in People With Lactose Intolerance and Ulcerative Colitis | April 2007 | June 2007 | |
| NCT00408174 | Completed | Phase 3 | Balsalazide Disodium vs. Mesalamine in Mildly to Moderately Active Ulcerative Colitis | May 2006 | November 2007 |
| NCT00408629 | Completed | Phase 3 | Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Active Ulcerative Colitis | November 2006 | March 2010 |
| NCT00409396 | Completed | N/A | A Study to Determine Whether Urinary PGE-M Levels Correlate With Ulcerative Colitis Disease | November 2006 | December 2007 |
| NCT00410410 | Completed | Phase 3 | A Study of Abatacept in Patients With Active Ulcerative Colitis | December 2006 | November 2009 |
| NCT00421642 | Completed | Phase 1 | Open-Label Adalimumab for Ulcerative Colitis Patients | October 2006 | April 2008 |
| NCT00430898 | Completed | Phase 2 | Basiliximab in Moderate to Severe Ulcerative Colitis | January 2007 | September 2008 |
| NCT00446849 | Completed | Phase 4 | Strategies in Maintenance for Patients Receiving Long-term Therapy (S.I.M.P.L.E.) With MMX (Multi-Matrix System) Mesalamine for Ulcerative Colitis (UC) | May 1, 2007 | August 17, 2009 |
| NCT00449722 | Completed | Phase 3 | OD vs. TID Dosing With Mesalazine Granules in Active Ulcerative Colitis | July 2005 | June 2006 |
| NCT00463619 | Completed | Follow-up Study With Retarded Release Phosphatidylcholine in Ulcerative Colitis | April 2000 | April 2010 | |
| NCT00467922 | Completed | Phase 3 | An Assessment of Goal-Directed Intraoperative Fluid Management in Hand Assisted Laparoscopic Colectomy | May 2007 | October 2009 |
| NCT00486031 | Completed | Phase 3 | Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study | October 2006 | December 2008 |
| NCT00490048 | Completed | N/A | Assessment of Pulmonary Involvement inUlcerative Colitis by Induced Sputum | June 2007 | June 2007 |
| NCT00498589 | Completed | Phase 2 | Comparison of Methotrexate vs Placebo in Corticosteroid-dependent Ulcerative Colitis | September 2007 | June 2014 |
| NCT00505778 | Completed | Phase 3 | A Comparison of Once a Day Dose Compared to 2 Doses/Day | July 2007 | July 2009 |
| NCT00516776 | Completed | The Innate Immune System and Inflammatory Bowel Disease | June 2007 | December 2017 | |
| NCT00521950 | Completed | N/A | Cost-effectiveness of TPMT Pharmacogenetics | September 2007 | December 2011 |
| NCT00542152 | Completed | Phase 4 | Study Comparing Cyclosporine With Infliximab in Steroid-refractory Severe Attacks of Ulcerative Colitis | June 2007 | October 2010 |
| NCT00548574 | Completed | Phase 3 | Efficacy and Safety of Two Doses of SPD476 (Mesalazine) 2.4g and 4.8g Once Daily, With Reference to Asacol 0.8g Three Times Daily in Subjects With Acute, Mild to Moderate Ulcerative Colitis | December 4, 2003 | October 20, 2004 |
| NCT00568256 | Completed | Phase 1 | Mind/Body Medicine and IBD Flare-Up | November 2007 | January 2011 |
| NCT00572585 | Completed | Phase 2 | Efficacy, Safety and Tolerability of AEB071 in Patients With Active, Moderate to Severe Ulcerative Colitis | April 2010 | April 2012 |
| NCT00573794 | Completed | Phase 3 | Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis | November 28, 2007 | December 2016 |
| NCT00577473 | Completed | Phase 3 | Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day (ASCEND I) | February 2001 | February 2003 |
| NCT00586352 | Completed | N/A | Protein Metabolism in Newly Diagnosed Pediatric Inflammatory Bowel Disease | January 2006 | November 2011 |
| NCT00586599 | Completed | N/A | Levels of the Stat4 Alpha and Stat4 Beta Isoforms in PBMCs From Patients With Crohn's Disease and Ulcerative Colitis | August 2007 | July 2014 |
| NCT00604422 | Completed | Evaluation of the PillCam™ Colon Capsule Endoscopy (PCCE) in Detection & Classification of Ulcerative Colitis | April 2007 | March 2010 | |
| NCT00618202 | Completed | N/A | A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Balsalazide Disodium 750 mg Capsules Under Fasting Conditions | May 2005 | June 2005 |
| NCT00618228 | Completed | N/A | Bioequivalency Study of Balsalazide Capsules Under Fasting Conditions | January 2004 | January 2004 |
| NCT00619489 | Completed | Phase 2 | Long Term Safety of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Disease | December 2007 | March 2010 |
| NCT00620126 | Completed | Phase 3 | The Home Telemanagement (UC HAT) Trial for Patients With Ulcerative Colitis | January 2008 | February 2010 |
| NCT00622557 | Completed | General Surgical Outcomes Quality Improvement Database (UH-SOCRATES) | May 1, 2007 | January 6, 2017 | |
| NCT00628433 | Completed | Phase 1/Phase 2 | Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitis | February 2008 | May 2009 |
| NCT00643071 | Completed | Phase 3 | Tacrolimus (FK506) P-III, Open-label Study in Refractory Ulcerative Colitis Patients | September 2006 | May 2008 |
| NCT00652145 | Completed | Phase 4 | Dose Escalation and Remission (DEAR) | September 2008 | January 2013 |
| NCT00656890 | Completed | Phase 2 | A Study of MDX-1100 in Subjects With Active Ulcerative Colitis | April 2008 | September 2009 |
| NCT00659802 | Completed | Phase 2 | Phase II Study of HMPL-004 in Patients With Ulcerative Colitis | February 7, 2008 | October 13, 2009 |
| NCT00679003 | Completed | N/A | Managing Inflammatory Bowel Disease | September 2007 | March 2014 |
| NCT00679380 | Completed | Phase 3 | (CB-01-02/02) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitis | June 2008 | April 2010 |
| NCT00679432 | Completed | Phase 3 | (CB-01-02/01) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitis | June 2008 | June 2010 |
| NCT00694980 | Completed | Phase 1 | A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of rhuMAb Beta7 in Patients With Ulcerative Colitis | September 2008 | September 2012 |
| NCT00705484 | Completed | European Safety Registry in Ulcerative Colitis (P04808) | June 1, 2007 | October 20, 2016 | |
| NCT00708656 | Completed | Phase 3 | The Colitis Once Daily Asacol Study | October 2006 | September 2010 |
| NCT00713310 | Completed | Phase 3 | Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents With Active Ulcerative Colitis | December 2008 | March 2011 |
| NCT00720538 | Completed | Phase 3 | Thalidomide in Pediatric Inflammatory Bowel Diseases. | August 2008 | June 2012 |
| NCT00727324 | Completed | Phase 2 | Safety/Efficacy Study of Bovine Intestinal Alkaline Phosphatase in Patients With Moderate to Severe Ulcerative Colitis | May 2006 | December 2006 |
| NCT00737789 | Completed | Phase 3 | Mesalazine 4g Once Daily Versus 4g in Two Divided Doses in Active Ulcerative Colitis. | November 2008 | June 2010 |
| NCT00744016 | Completed | Phase 3 | Mesalamine Pellet Formulation to Maintain Remission of Mild to Moderate Ulcerative Colitis | December 2004 | October 2007 |
| NCT00767728 | Completed | Phase 3 | Mesalamine Pellet to Maintain Remission of Mild to Moderate Ulcerative Colitis | December 2004 | October 2007 |
| NCT00769353 | Completed | N/A | Understanding and Treating Neuropsychiatric Symptoms of Pediatric Physical Illness | January 2008 | January 2014 |
| NCT00780507 | Completed | Fecal Biomarker Study for Patients With Ulcerative Colitis | August 2007 | July 2009 | |
| NCT00781638 | Completed | N/A | ADAPT Adacolumn Pediatric Trial in Ulcerative Colitis | October 2008 | March 2012 |
| NCT00783718 | Completed | Phase 3 | Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis | January 2009 | March 2012 |
| NCT00787202 | Completed | Phase 2 | A Study To Investigate The Safety And Efficacy Of CP- 690,550 In Patients With Moderate And Severe Ulcerative Colitis. | December 2008 | September 2010 |
| NCT06069167 | Completed | Bowel Urgency in Inflammatory Bowel Disease | October 12, 2023 | March 22, 2024 | |
| NCT00790933 | Completed | Phase 3 | An Open-label Study of Vedolizumab (MLN0002) in Participants With Ulcerative Colitis and Crohn's Disease | May 22, 2009 | October 31, 2017 |
| NCT00791557 | Completed | N/A | Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel Disease | October 2008 | February 2010 |
| NCT00798642 | Completed | N/A | Ulcerative Colitis Relapse Prevention Trial, Hypnosis | July 2007 | June 2012 |
| NCT00801723 | Completed | Phase 3 | (CB-01-02/04) Extension Study of Budesonide Multi-Matrix System (MMX) 6 mg in Maintenance Of Remission In Patients With Ulcerative Colitis. | December 2008 | June 2011 |
| NCT00803829 | Completed | N/A | Synbiotic Treatment of Ulcerative Colitis Patients | January 2009 | January 2011 |
| NCT06023667 | Completed | N/A | SMART-IBD App Trial | December 14, 2022 | December 28, 2023 |
| NCT00808977 | Completed | Phase 2 | A Phase II Study to Explore the Safety and Activity of Dersalazine in Patients With Mild to Moderate Ulcerative Colitis | December 2008 | June 2010 |
| NCT00810030 | Completed | Phase 3 | FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR | October 2008 | April 2010 |
| NCT00816491 | Completed | N/A | Comparison Between Chromoendoscopy and Conventional Colonoscopy to Improve the Detection of Neoplasia in Patients With Ulcerative Colitis (UC) | October 2008 | November 9, 2013 |
| NCT00829595 | Completed | N/A | Pneumococcal Vaccination in Patients With Inflammatory Bowel Disease | May 2005 | December 2007 |
| NCT00853099 | Completed | Phase 3 | A Study of Adalimumab in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis | February 2009 | August 2013 |
| NCT00867438 | Completed | Phase 2 | Efficacy and Tolerability of a New Oral Extended-Release Formulation Containing Parnaparin Sodium, Administered Add-on Therapy | January 2007 | November 2007 |
| NCT05992142 | Completed | Phase 4 | ChAracterizing the Remission Status in Patients With Ulcerative Colitis Treated by 5-ASA | January 17, 2023 | February 1, 2024 |
| NCT00889161 | Completed | Phase 1 | Curcumin in Pediatric Inflammatory Bowel Disease | May 2009 | June 2010 |
| NCT00917514 | Completed | An Investigational Study to Test Usability of the Electronic Dosing Equipment Medicpen | June 2009 | February 2010 | |
| NCT00940576 | Completed | N/A | Dietetic Efficacy of Mare's Milk for Patients With Chronic Inflammatory Bowel Diseases | July 2000 | February 2001 |
| NCT00951548 | Completed | N/A | Food Supplementation With VSL#3 as a Support to Standard Pharmaceutical Therapy in Ulcerative Colitis | October 2006 | October 2008 |
| NCT00961948 | Completed | Indigo Carmine Staining and Narrow Band Imaging (NBI) of Colonic Mucosa for Detection of Dysplasia in Ulcerative Colitis | June 2009 | February 2013 | |
| NCT00963287 | Completed | N/A | Trial of Chinese Prescription on Ulcerative Colitis | August 2009 | August 2011 |
| NCT05927064 | Completed | Study Evaluating the Persistence, Efficacy and Tolerability of Methotrexate in Inflammatory Bowel Disease Patients | July 21, 2023 | January 12, 2024 | |
| NCT01020708 | Completed | Phase 1 | Study of the Safety and Tolerability of ALTH12 Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis | November 2009 | September 2010 |
| NCT01026857 | Completed | Phase 2 | Propionyl-L-Carnitine in Ulcerative Colitis | May 2006 | December 2009 |
| NCT01032525 | Completed | Monroe County Inflammatory Bowel Disease (IBD) Registry | January 1981 | March 2014 | |
| NCT01037322 | Completed | Phase 1/Phase 2 | Cannabidiol for Inflammatory Bowel Disease | January 2010 | September 2012 |
| NCT05844592 | Completed | Phase 1 | First in Human, Single Ascending Dose Study | April 21, 2022 | August 31, 2022 |
| NCT01059344 | Completed | Phase 3 | Efficacy and Safety of Asacol™ 4.8 g/Day (800 mg Tablets) for the Treatment of Active Ulcerative Colitis | November 2009 | August 2011 |
| NCT01065571 | Completed | N/A | Effects of Carrageenan-Elimination Diet on Ulcerative Colitis Disease Activity | January 2010 | January 2014 |
| NCT01090154 | Completed | Phase 2 | Study of Cimzia for the Treatment of Ulcerative Colitis | December 1, 2010 | December 10, 2021 |
| NCT01091558 | Completed | Study of Effects of L-Arginine in Colitis and Colon Cancer | September 2009 | December 2011 | |
| NCT01095042 | Completed | N/A | Cognition and Emotion in the SII and IBD | October 2008 | May 2013 |
| NCT01095432 | Completed | Partial Wave Spectroscopic Detection of Colon Cancer Risk | March 2010 | November 2015 | |
| NCT01097590 | Completed | Phase 1 | A Study to Evaluate a Leukapheresis Treatment in Patients With Ulcerative Colitis | March 2010 | November 2011 |
| NCT01104753 | Completed | A Study of Pentasa in Patients With Ulcerative Colitis | September 2009 | March 2011 | |
| NCT05807971 | Completed | Phase 1 | Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ATH-063 in Healthy Subjects | April 6, 2023 | February 8, 2024 |
| NCT01124149 | Completed | Phase 4 | Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis | June 29, 2010 | December 7, 2012 |
| NCT01130844 | Completed | Phase 1 | Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis | October 8, 2010 | June 27, 2013 |
| NCT00004810 | Completed | Phase 2 | Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative Colitis | June 1996 | |
| NCT01149694 | Completed | Phase 1 | A Study to Assess the Safety and Tolerability of PUR 0110 Rectal Enema in Normal Healthy Volunteers | June 2009 | August 2009 |
| NCT01173250 | Completed | N/A | Is Diverting Ileostomy Necessary in Stapled Ileoanal Pouch? | ||
| NCT01177228 | Completed | Phase 2 | Study of Vedolizumab Following Multiple Intravenous Doses in Patients With Ulcerative Colitis | May 2007 | September 2008 |
| NCT01193894 | Completed | Phase 2/Phase 3 | Trial on Profermin and Fresubin in Ulcerative Colitis | August 2010 | December 2012 |
| NCT05761327 | Completed | N/A | Investigation of the Effects of Curcumin and Resveratrol Supplements Added to the Mediterranean Diet on Disease Severity and Inflammatory Biomarkers in Patients With Ulcerative Colitis | June 3, 2022 | March 22, 2024 |
| NCT03773445 | Completed | Golimumab Trough Levels in Patients With Ulcerative Colitis | March 1, 2019 | September 30, 2021 | |
| NCT03760003 | Completed | Phase 2 | Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis | September 23, 2019 | April 16, 2021 |
| NCT03757065 | Completed | Cell Surface Marker Expression in Autoimmune Diseases | June 12, 2019 | October 25, 2019 | |
| NCT03663400 | Completed | Identify Predictors That Distinguish Between Tofacitinib Responders and Non-responders Based on Genotype and Cellular and Molecular Profiles From Pinch Biopsies, Blood and Stool Samples | December 4, 2018 | March 24, 2022 | |
| NCT00064454 | Completed | Phase 3 | FACTS II: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis | May 2003 | July 2006 |
| NCT03671980 | Completed | N/A | IBD Self-management Website and Home Faecal Calprotectin Monitoring | April 4, 2017 | June 30, 2018 |
| NCT03675477 | Completed | Phase 2 | A Phase II Study in Patients With Moderate to Severe Active Ulcerative Colitis. | April 13, 2019 | February 3, 2021 |
| NCT00065065 | Completed | Phase 2 | A Trial of Rosiglitazone for Ulcerative Colitis | September 2002 | January 2008 |
| NCT03689673 | Completed | Study of the Effectiveness of ETIASA® (Sustained Release 5-Aminosalicylate) in Maintenance Treatment of Ulcerative Colitis (UC) | April 24, 2013 | November 16, 2020 | |
| NCT03747068 | Completed | The Influence of Biologcal Treatment on the Short-Term Complications of Surgery in Patients With Inflematory Bowel Disease. | October 9, 2009 | October 9, 2015 | |
| NCT03705117 | Completed | Phase 1 | Open-label V565 Target Engagement Study | May 23, 2017 | October 24, 2017 |
| NCT03711006 | Completed | Phase 1/Phase 2 | The Effect of Fecal Microbiota Transplantation in Ulcerative Colitis | February 1, 2017 | November 30, 2017 |
| NCT03720002 | Completed | Phase 1/Phase 2 | HF2 Therapy in the Treatment of Active Ulcerative Colitis | May 29, 2019 | February 1, 2023 |
| NCT00073021 | Completed | Phase 3 | Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis | September 2000 | September 2003 |
| NCT00073047 | Completed | Phase 2 | Humanized Anti-IL-2 Receptor Monoclonal Antibody in Moderate-to-severe Ulcerative Colitis | April 2003 | July 2006 |
| NCT00092508 | Completed | Phase 3 | CORE: A Study of OPC-6535 With Asacol® in Maintaining Ulcerative Colitis (UC) Remission | May 2004 | May 2007 |
| NCT00096655 | Completed | Phase 3 | A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Ulcerative Colitis | May 2002 | August 2007 |
| NCT00102193 | Completed | Phase 3 | Study for the Treatment of Ulcerative Colitis With Adacolumn | July 2004 | July 2006 |
| NCT00114803 | Completed | N/A | Nasal Calcitonin in the Treatment of Bone Mineral Loss in Children and Adolescents With Inflammatory Bowel Disease | January 2004 | October 2006 |
| NCT00145015 | Completed | N/A | FishGastro Study: Fish Consumption and Gastro-Intestinal Health | December 2004 | April 2008 |
| NCT00145808 | Completed | Phase 3 | Wireless Capsule Endoscopy in Ulcerative Colitis | June 2005 | November 2008 |
| NCT00151892 | Completed | Phase 3 | Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis | April 8, 2005 | September 7, 2009 |
| NCT00167882 | Completed | Phase 4 | The Influence of 5-Aminosalicylates on Thiopurine Metabolite Levels | July 2005 | August 2006 |
| NCT00194818 | Completed | Phase 4 | Asacol Dosing Study for Active Ulcerative Colitis | June 2003 | August 2007 |
| NCT00207688 | Completed | A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients | August 31, 2004 | September 9, 2015 | |
| NCT00209300 | Completed | Phase 3 | Pentasa Once Daily in Ulcerative Colitis for Maintenance of Remission | May 2005 | June 2007 |
| NCT00215020 | Completed | Evaluation of Urinary Isoprostanes in the Assessment of Children With Inflammatory Bowel Disease | September 2003 | June 2006 | |
| NCT00219414 | Completed | Phase 4 | Study for the Treatment of Ulcerative Colitis With Adacolumn (Companion to US Study 512-04-205) | June 2005 | June 2006 |
| NCT00222378 | Completed | Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel Disease | April 2005 | June 2012 | |
| NCT00232258 | Completed | Phase 2 | Nolpitantium Besylate In Patients With Ulcerative Colitis a Double-Blind, Placebo Controlled Efficacy and Safety Study | April 2005 | September 2006 |
| NCT00259545 | Completed | Phase 2 | Retarded Phosphatidylcholine in Steroid-Dependent Chronic Active Ulcerative Colitis | February 2003 | February 2006 |
| NCT00259558 | Completed | Phase 2 | Dose Finding Study for Retarded Phosphatidylcholine in Pancolitis | April 2003 | March 2006 |
| NCT00261118 | Completed | Phase 2/Phase 3 | Rituximab in Active Ulcerative Colitis | April 2004 | October 2009 |
| NCT00269438 | Completed | Phase 3 | New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative Colitis | December 2005 | June 2007 |
| NCT00274209 | Completed | Chromoendoscopy for Ulcerative Colitis Surveillance | December 2005 | November 2011 | |
| NCT00295282 | Completed | Phase 1 | A Dose-Escalation Study of MDX-1100 in Patients With Active Ulcerative Colitis | January 2006 | January 2008 |
| NCT00299013 | Completed | Phase 3 | Study of COLAL-PRED® in the Treatment of Moderate Acute Ulcerative Colitis | March 2006 | April 2008 |
| NCT00303381 | Completed | Phase 2 | Safety and Efficacy of Interferon-Beta-1a (Rebif®) for Treating Subjects With Acute Symptoms of Ulcerative Colitis | December 2001 | January 2003 |
| NCT00326209 | Completed | Phase 3 | Long-Term Safety and Tolerability of Mesalamine Pellets in Participants With Ulcerative Colitis in Remission | December 22, 2005 | May 5, 2008 |
| NCT00336492 | Completed | Phase 3 | A Study of the Safety and Efficacy of Infliximab(REMICADE ) in Pediatric Patients With Moderately to SeverelyActive Ulcerative Colitis | September 2006 | April 2010 |
| NCT00343850 | Completed | Phase 3 | Once Daily Versus Conventional Dosing of Asacol in the Maintenance of Quiescent Ulcerative Colitis | September 2006 | March 2007 |
| NCT00347048 | Completed | Phase 3 | Tacrolimus (FK506) Study in Moderate to Severe Refractory Ulcerative Colitis Patients | September 2006 | April 2008 |
| NCT00350415 | Completed | Phase 3 | A Double Blind Study for the Treatment of Acute Ulcerative Colitis | June 2006 | May 2007 |
| NCT00352404 | Completed | Phase 3 | Chromoscopic Guided Endomicroscpy to Diagnose Colitis Associated Dysplasia | August 2003 | November 2004 |
| NCT00366925 | Completed | N/A | CESA 5.10 Investigation to Compare the Efficacy and Safety of the Adacolumn® Apheresis Device in Patients With Active Ulcerative Colitis | April 2006 | July 2008 |
| NCT00374725 | Completed | N/A | Treatment of Ulcerative Colitis With a Combination of Lactobacillus Rhamnosus and Lactobacillus Acidophilus. | February 2003 | May 2006 |
| NCT04205643 | Completed | Phase 3 | CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Ulcerative Colitis (LIBERTY-UC) | September 1, 2020 | July 11, 2023 |
| NCT03178669 | Completed | Phase 2 | The Efficacy of Cobitolimod in Patients With Moderate to Severe Active Ulcerative Colitis | June 21, 2017 | August 30, 2019 |
| NCT03179865 | Completed | Evaluation of Early Mucosal Healing During Clinical Remission in Pediatric Ulcerative Colitis | January 2016 | November 2020 | |
| NCT03182166 | Completed | Phase 2 | Golimumab in Ulcerative Colitis (UC) Patients With Loss of Response (LOR) Followed by Dose Optimization | November 21, 2017 | December 15, 2021 |
| NCT03189888 | Completed | N/A | Granulocyte-monocyte Apheresis in Ulcerative Colitis | January 2013 | December 2013 |
| NCT04191707 | Completed | Metabolomic Markers of Fatigue in Inflammatory Bowel Disease | November 1, 2013 | December 1, 2019 | |
| NCT03232528 | Completed | N/A | The Promotion Plan of Moxibustion on Ulcerate Colitis | November 1, 2016 | December 30, 2019 |
| NCT04188990 | Completed | N/A | Cost Effectiveness of an Intervention in Hospitalized Patients With Disease-related Malnutrition | June 15, 2020 | June 30, 2023 |
| NCT04151420 | Completed | Real Life Remote Monitoring of Mild, Moderate and Severe Infectious Complications in IBD by Patient Reported Assessment | June 15, 2020 | February 1, 2022 | |
| NCT00048347 | Completed | Phase 2 | Interferon-beta1a (AVONEX) Treatment of Ulcerative Colitis | October 2002 | May 2010 |
| NCT04147598 | Completed | N/A | Diet Study on Ulcerative Colitis | February 25, 2015 | September 11, 2018 |
| NCT04071405 | Completed | Korea Post-marketing Surveillance for Xeljanz (Registered) in Ulcerative Colitis Patients | May 12, 2020 | September 26, 2022 | |
| NCT03262649 | Completed | Manitoba Inflammatory Bowel Disease Cohort Study | March 1, 2002 | October 1, 2016 | |
| NCT03268213 | Completed | Early Phase 1 | Fecal Microbial Transplantation for C. Difficile and/or Ulcerative Colitis or Indeterminate Colitis | November 2013 | February 15, 2022 |
| NCT04018599 | Completed | Phase 1 | Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS | July 15, 2019 | March 17, 2020 |
| NCT04018040 | Completed | N/A | Vegetarian Diet in IBD | May 6, 2019 | August 10, 2023 |
| NCT03282903 | Completed | The PRognostic Effect of Environmental Factors in Crohn's and Colitis | November 1, 2016 | March 20, 2022 | |
| NCT03283085 | Completed | Phase 3 | A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) | February 27, 2018 | December 13, 2023 |
| NCT03290781 | Completed | Phase 3 | An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis | April 4, 2018 | July 1, 2021 |
| NCT04004611 | Completed | Phase 2 | A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC) | May 18, 2020 | March 15, 2023 |
| NCT03301311 | Completed | N/A | Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease | April 10, 2018 | September 8, 2020 |
| NCT04000139 | Completed | Phase 2 | Anthocyanin Rich Extract (ACRE) in Patients With Ulcerative Colitis | April 1, 2019 | March 11, 2021 |
| NCT03998488 | Completed | Phase 2 | Examining the Efficacy of Fecal Microbiota Transplantation (FMT) and Dietary Fiber in Patients With Ulcerative Colitis | January 31, 2020 | April 12, 2024 |
| NCT03996369 | Completed | Phase 3 | Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis | September 15, 2020 | December 7, 2021 |
| NCT03327558 | Completed | Phase 1 | Randomized,Study of APRISO 375 mg Versus the Approved APRISO 375 mg Capsules in Healthy Male and Female Subjects | May 15, 2017 | August 18, 2017 |
| NCT03338894 | Completed | N/A | A Trial of Yoga in Pediatric Inflammatory Bowel Disease | December 13, 2017 | December 31, 2021 |
| NCT03952195 | Completed | Complications and Outcomes of Pouch Excision | November 1, 2015 | April 1, 2018 | |
| NCT03948919 | Completed | Phase 1 | Low Sulfur Fecal Transplant for Ulcerative Colitis | July 31, 2019 | January 4, 2024 |
| NCT03359642 | Completed | N/A | Characterization of the Intestinal Microbiota in Patients With Inflammatory Bowel Disease and/or Spondyloarthritis and Study of the Impact of an Anti-TNF Alpha Therapy | June 5, 2018 | September 16, 2021 |
| NCT03947931 | Completed | Russian Extremely Severe Ulcerative Colitis Study | June 20, 2019 | June 20, 2022 | |
| NCT03945188 | Completed | Phase 3 | Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis | June 13, 2019 | February 16, 2022 |
| NCT03378921 | Completed | Phase 2 | Fecal Microbiota Transplantation (FMT) in the Treatment of Pouchitis | February 27, 2018 | September 25, 2019 |
| NCT03941184 | Completed | Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity | January 1, 1995 | November 10, 2020 | |
| NCT03404557 | Completed | Proteomic Analysis of Crohn's Disease Macrophages in Response or Not to AIEC | January 18, 2018 | January 18, 2019 | |
| NCT03934216 | Completed | Phase 2 | Safety and Efficacy of Deucravacitinib in Participants With Moderate to Severe Ulcerative Colitis | July 1, 2019 | April 4, 2023 |
| NCT03452501 | Completed | Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia Patients | August 26, 2018 | August 17, 2020 | |
| NCT03884439 | Completed | Infliximab Biosimilar "Pfizer" Drug Use Investigation (Crohn's Disease or Ulcerative Colitis) | March 18, 2019 | February 2, 2024 | |
| NCT03861143 | Completed | Phase 2 | Efficacy and Safety of Oral BT-11 in Ulcerative Colitis | August 14, 2019 | June 17, 2021 |
| NCT03482648 | Completed | Phase 1 | First-In-Human Study of BBT-401-1S Following Single and Multiple Ascending Doses in Healthy Volunteers | March 20, 2018 | October 3, 2018 |
| NCT03860896 | Completed | Phase 1 | GB004 in Adult Subjects With Active Ulcerative Colitis | April 24, 2019 | December 17, 2019 |
| NCT03512327 | Completed | N/A | Autoimmune Protocol Diet and Inflammatory Bowel Disease | September 1, 2016 | December 10, 2016 |
| NCT00061737 | Completed | Quality of Life in Pediatric Inflammatory Bowel Disease | January 2003 | ||
| NCT03849599 | Completed | Phase 1 | A Study to Evaluate the Safety of PRV-300 in Adult Subjects With Moderately to Severely Active Ulcerative Colitis | February 21, 2018 | March 1, 2019 |
| NCT03836612 | Completed | Healthcare Resource Utilisation, Common Mental Health Problems, and Infections in People With Inflammatory Bowel Disease | February 1, 2019 | November 1, 2019 | |
| NCT03538366 | Completed | N/A | Fecal Microbiota Transplantation for Chronic Pouchitis | May 15, 2018 | May 1, 2019 |
| NCT03546868 | Completed | Phase 2 | Diagnostic Validity of [18F]FSPG PET for the Assessment of Disease Activity in Inflammatory Bowel Disease | August 14, 2018 | January 11, 2019 |
| NCT03553472 | Completed | Identifying Young Inflammatory Bowel Disease Patients at Risk for Herpes Zoster | January 1, 2018 | May 31, 2019 | |
| NCT03558152 | Completed | Phase 2 | A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC) | October 26, 2018 | December 15, 2021 |
| NCT03835780 | Completed | The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort Study | February 1, 2019 | December 1, 2019 | |
| NCT03565432 | Completed | Sick Leave, Work Disability and Quality of Life in Korean Patients With Inflammatory Bowel Diseases | March 9, 2018 | February 19, 2020 | |
| NCT00063414 | Completed | Phase 2 | ISIS 2302-CS22, A 6-Week, Active-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitis | November 20, 2002 | March 24, 2005 |
| NCT03574948 | Completed | Phase 2 | 5-HTP in Patients With IBD in Clinical and Biologic Remission:Effect on Fatigue Scores | December 6, 2018 | March 3, 2021 |
| NCT03832400 | Completed | Phase 1 | Safety and Efficacy of Microbial Ecosystem Therapeutic-2 (MET-2) in Patients With Ulcerative Colitis (UC) | February 4, 2019 | March 1, 2020 |
| NCT03824418 | Completed | The Clinical Value of Chromoendoscopy as Surveillance Strategy for Dysplasia Detection in Ulcerative Colitis | May 9, 2016 | October 1, 2018 | |
| NCT00063830 | Completed | Phase 2 | ISIS 2302-CS27, A 6-Week, Placebo-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitis. | April 3, 2003 | October 11, 2004 |
| NCT03794765 | Completed | Phase 2 | Antibiotics as an Adjuvant in Patients With Acute Severe Ulcerative Colitis | April 1, 2019 | April 4, 2020 |
| NCT03781284 | Completed | N/A | PET Combined With MRI for Monitoring Inflammatory Activity in Patients With Ulcerative Colitis | January 1, 2016 | October 31, 2018 |
| NCT00064441 | Completed | Phase 3 | FACTS I: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis | May 2003 | May 2006 |
| NCT03773952 | Completed | Phase 2 | Safety and Efficacy of PBF-677 in Ulcerative Colitis Patients | July 1, 2018 | May 27, 2021 |
| NCT03643211 | Completed | Xeljanz Special Investigation for Long-term Use in UC Patients | June 8, 2018 | November 10, 2022 | |
| NCT01245465 | Completed | Phase 1/Phase 2 | Profermin® in Active Ulcerative Colitis | January 2009 | November 2009 |
| NCT01282905 | Completed | Hydrogen Sulfide Detoxification and Butyrate Metabolism in Ulcerative Colitis | October 2008 | December 2010 | |
| NCT01287195 | Completed | Phase 1/Phase 2 | Oral OKT3 for the Treatment of Active Ulcerative Colitis | April 7, 2011 | May 2, 2013 |
| NCT01289366 | Completed | Endocytoscopy for in Vivo Determination of Mucosal Inflammatory Cells and Intestinal Disease Activity in Inflammatory Bowel Disease (IBD) | May 2010 | August 2011 | |
| NCT01290042 | Completed | Phase 1 | Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181. | February 2011 | May 2014 |
| NCT05728008 | Completed | Retrospective Observational Comparison Study Between Ustekinumab and Tofacitinib as Third Line Therapy in a Multicenter Cohort of Patients With Refractory Ulcerative Colitis. | April 5, 2022 | July 5, 2022 | |
| NCT01296841 | Completed | Phase 2 | Telemedicine To Provide Inflammatory Bowel Disease Outpatient Care | October 2009 | June 2010 |
| NCT01320332 | Completed | Phase 1 | A Study of a Single Dose of ASP3291 in Subjects With Ulcerative Colitis | August 2010 | August 2011 |
| NCT01320436 | Completed | Phase 3 | Curcumin + Aminosalicylic Acid (5ASA) Versus 5ASA Alone in the Treatment of Mild to Moderate Ulcerative Colitis | July 2011 | October 2014 |
| NCT01336465 | Completed | Phase 2 | Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis | September 2011 | June 2013 |
| NCT01339273 | Completed | N/A | Transversus Abdominis Plane (TAP) Block for Postoperative Analgesia After Laparoscopic Colonic Resection | September 2011 | December 2015 |
| NCT01340872 | Completed | Phase 3 | Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Ulcerative Colitis (AEGIS-1) | August 2011 | October 2014 |
| NCT01341808 | Completed | Phase 4 | Immunogenicity of Hepatitis A Vaccine in Inflammatory Bowel Disease (IBD) Patients | April 2011 | March 2013 |
| NCT01346826 | Completed | Phase 4 | Safety of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease (IBD) | May 2011 | April 2016 |
| NCT01349504 | Completed | Adherence to Mesalamine Profile for Patients With Inflammatory Bowel Disease | April 2011 | December 2012 | |
| NCT01363453 | Completed | User Surveillance in Ulcerative Colitis | October 2007 | July 2008 | |
| NCT01387594 | Completed | Phase 1 | Evaluate PF-00547659 On Cerebrospinal Fluid Lymphocytes In Volunteers With Crohn's Disease Or Ulcerative Colitis Who Failed Or Did Not Tolerate Anti-TNFs | May 3, 2012 | November 26, 2015 |
| NCT01387698 | Completed | Prospective, Longitudinal Multicentric Survey in the Therapeutic Care of Mild to Moderate Ulcerative Colitis | June 2011 | October 2015 | |
| NCT01393405 | Completed | Phase 2 | Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis | February 2012 | April 2017 |
| NCT01405105 | Completed | Exacerbating Factors in Inflammatory Bowel Disease | August 2009 | June 2012 | |
| NCT01408810 | Completed | Phase 4 | Evaluation of Histologic and Endoscopic Remission Induced by Infliximab in Moderate to Severe Ulcerative Colitis | February 2011 | November 2012 |
| NCT01417702 | Completed | Endoscopy for Assessment of Mucosal Healing in IBD | August 2011 | November 2014 | |
| NCT01417715 | Completed | Endomicroscopy for Assessment of Mucosal Healing | August 2011 | August 2014 | |
| NCT01417728 | Completed | Endomicroscopy in IBD Patients | May 2011 | August 2013 | |
| NCT01418131 | Completed | Phase 4 | Rectal Tacrolimus in the Treatment of Resistant Ulcerative Proctitis | October 2012 | November 2016 |
| NCT01433471 | Completed | N/A | Mucosal Immunity of Ulcerative Colitis Patients Undergoing Therapy With Trichuris Suis Ova | August 2012 | May 2015 |
| NCT01456052 | Completed | Phase 2 | A Study to Evaluate Safety and Efficacy of Telotristat Etiprate (LX1606) in Participants With Acute, Mild to Moderate Ulcerative Colitis | January 30, 2012 | September 3, 2013 |
| NCT01458574 | Completed | Phase 3 | A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis | July 20, 2012 | May 27, 2016 |
| NCT01458951 | Completed | Phase 3 | A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis | June 2012 | June 2015 |
| NCT01461317 | Completed | Phase 2 | Study to Evaluate the Long-term Safety of Etrolizumab in Participants With Moderate to Severe Ulcerative Colitis | November 29, 2011 | August 7, 2016 |
| NCT01465763 | Completed | Phase 3 | A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis | April 2012 | May 2015 |
| NCT01467609 | Completed | PillCam Colon Capsule Endoscopy for Ulcerative Colitis | July 2009 | November 2010 | |
| NCT01468090 | Completed | Disease Course in an IBD Cohort in the Era of Biological Treatment | October 2011 | June 2014 | |
| NCT01470612 | Completed | Phase 3 | Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis | October 1, 2012 | August 6, 2020 |
| NCT01476995 | Completed | Prognostic Indicators as Provided by the EPIC ClearView | September 2010 | June 2011 | |
| NCT01482884 | Completed | Phase 2 | Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis | March 2012 | June 2013 |
| NCT01491997 | Completed | N/A | Mind-Body Medicine and Ulcerative Colitis | August 2011 | July 2017 |
| NCT01496053 | Completed | Phase 2/Phase 3 | Anti-inflammatory Effect of Agaricus Blazei Murill in Inflammatory Bowel Disease (IBD) | December 2011 | January 2016 |
| NCT01506362 | Completed | Phase 2 | Efficacy, Pharmacodynamics, Safety and Tolerability of Oral BL-7040 in Patients With Moderately Active Ulcerative Colitis | March 2012 | May 2013 |
| NCT01517516 | Completed | Multi Modal Imaging: An MRI Study to Investigate Differences in the Structure and the Function of the Brain at Rest. | March 2011 | July 2015 | |
| NCT01517594 | Completed | Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis | October 2011 | June 2013 | |
| NCT01517607 | Completed | Mesalazine (PENTASA®) in Ulcerative Colitis | February 2012 | December 2013 | |
| NCT01520324 | Completed | Phase 2 | Neoplasia Detection With Methylene Blue MMX Tablets in Patients With UC Undergoing Colonoscopy | January 2012 | July 2012 |
| NCT01532648 | Completed | Phase 3 | Randomized Placebo-Controlled Trial of Budesonide Multi-Matrix System (MMX®) 9 Milligrams (mg) in Participants With Ulcerative Colitis Currently on a 5-Aminosalicylic Acid (5-ASA) | January 27, 2012 | October 2, 2013 |
| NCT01536509 | Completed | N/A | Improving Medication Adherence in Pediatric Inflammatory Bowel Disease | February 2012 | May 31, 2016 |
| NCT01536535 | Completed | Phase 4 | Predicting Response to Standardized Pediatric Colitis Therapy | July 10, 2012 | April 30, 2018 |
| NCT01545908 | Completed | Phase 2 | Fecal Biotherapy for the Induction of Remission in Active Ulcerative Colitis | March 2012 | August 2014 |
| NCT01550965 | Completed | Phase 3 | A Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting | May 2012 | April 2015 |
| NCT01551290 | Completed | Phase 3 | A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis | April 2012 | October 2014 |
| NCT01562314 | Completed | Phase 2 | A Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis (GWID10160) | May 9, 2012 | August 5, 2014 |
| NCT05649462 | Completed | Effect of Vitamin D Supplementation on Vedolizumab Response in Patients With Ulcerative Colitis | January 1, 2020 | June 1, 2022 | |
| NCT05645666 | Completed | N/A | The Effectiveness of Well-being Therapy on Mental Health and Self-efficacy of Patients With Ulcerative Colitis | March 1, 2022 | October 1, 2022 |
| NCT01612039 | Completed | Phase 2 | Safety, Efficacy, and Tolerability Study of ASP3291 in Patients With Active Ulcerative Colitis | July 2012 | April 2014 |
| NCT01620255 | Completed | Phase 2 | A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis | November 2, 2012 | February 4, 2016 |
| NCT01647516 | Completed | Phase 2 | Efficacy and Safety Study of Ozanimod in Ulcerative Colitis | December 26, 2012 | August 30, 2019 |
| NCT01650038 | Completed | Phase 2 | Transplantation of Faeces in Ulcerative Colitis; Restoring Nature's Homeostasis | May 2011 | December 2014 |
| NCT01654783 | Completed | Observational Study in the Management of Ulcerative Colitis With Oral 5-ASA | September 2012 | June 2014 | |
| NCT01670240 | Completed | Phase 3 | Adalimumab in the Treatment of Chronic Pouchitis | August 2012 | January 2016 |
| NCT01676324 | Completed | FOCUS: The Future of Fecal Calprotectin Utility Study for the Diagnosis and Management of Inflammatory Bowel Disease (IBD) | September 2012 | September 2013 | |
| NCT01678300 | Completed | Qualitative Study of Topical Mesalamine Adherence in Patients With Ulcerative Colitis(UC) | August 2012 | November 2015 | |
| NCT05596422 | Completed | A Study of Vedolizumab and Biologic Agents in Participants With Inflammatory Bowel Disease (IBD) | May 27, 2021 | December 8, 2022 | |
| NCT01692743 | Completed | Phase 3 | Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD) | September 2012 | September 2016 |
| NCT01694485 | Completed | Phase 2 | Abrilumab (AMG 181) in Adults With Moderate to Severe Ulcerative Colitis | November 16, 2012 | April 10, 2018 |
| NCT05530122 | Completed | Prognosis in UC After First Biological | January 2009 | August 26, 2022 | |
| NCT00032305 | Completed | Phase 2/Phase 3 | Research Study in Patients With Severe Ulcerative Colitis | March 2002 | November 2005 |
| NCT05500040 | Completed | Changes in Faecal Calprotectin Levels and Participation-related Scores Following Three Weeks of Inpatient Rehabilitation | August 9, 2022 | July 26, 2023 | |
| NCT01757964 | Completed | Phase 1 | Bacteriotherapy in Pediatric Inflammatory Bowel Disease | December 2012 | January 2015 |
| NCT01759056 | Completed | Phase 1 | Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis | February 2013 | December 2013 |
| NCT01764542 | Completed | N/A | Development of Dysplasia in the Pelvic Pouch in Patients With Ulcerative Colitis (UC) and Risk Factors | February 2010 | February 2015 |
| NCT01768858 | Completed | Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice | February 5, 2013 | August 13, 2017 | |
| NCT01771809 | Completed | Phase 2 | Long-Term Safety Of PF-00547659 In Ulcerative Colitis | March 18, 2013 | December 13, 2017 |
| NCT01772615 | Completed | Phase 4 | Treatment of Ulcerative Colitis With Ciprofloxacin and E. Coli Nissle | May 2011 | August 2013 |
| NCT05458531 | Completed | Monitoring of Inflammatory Conditions | June 28, 2022 | February 8, 2023 | |
| NCT05405465 | Completed | Effectiveness of Golimumab in Patients With Ulcerative Colitis: Results of a Real-life Study in Switzerland | January 1, 2018 | June 1, 2021 | |
| NCT00033943 | Completed | Phase 2/Phase 3 | Safety and Efficacy of OP2000 (Deligoparin) in the Treatment of Active Ulcerative Colitis | January 2001 | September 2002 |
| NCT01798953 | Completed | Surgical Reconstruction in Ulcerative Colitis With Primary Sclerosing Cholangitis | January 2010 | November 2013 | |
| NCT05372939 | Completed | Phase 2 | Study of the Efficacy and Safety of AMT-101 in Combination With Adalimumab in Subjects With Ulcerative Colitis (MARKET) | February 5, 2021 | July 13, 2022 |
| NCT01813500 | Completed | Host Immune Response to Clostridium Difficile Infection in Inflammatory Bowel Disease Patients | October 2011 | April 2016 | |
| NCT01829321 | Completed | Phase 2 | Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Study of GLPG0974 in Subjects With Ulcerative Colitis | April 2013 | April 2014 |
| NCT01831427 | Completed | Phase 1 | Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of GS-5745 (Andecaliximab) in Adults With Moderate to Severe Active Ulcerative Colitis | March 28, 2013 | February 6, 2015 |
| NCT01837615 | Completed | Phase 2 | Assessment of Photopill Capsule Treatment for Safety and Feasibility in Ulcerative Proctitis | January 2013 | June 2015 |
| NCT01839214 | Completed | Phase 2 | A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With Ulcerative Colitis | January 2013 | November 2014 |
| NCT01852760 | Completed | Assessment of Disease Activity in Ulcerative Colitis by Endoscopic Ultrasound | September 2013 | July 2015 | |
| NCT01860651 | Completed | N/A | Web-based Monitoring in Children and Adolescents With Inflammatory Bowel Disease | September 2013 | May 2017 |
| NCT05214404 | Completed | Effect and Mechanism of Dopamine on Ulcerative Colitis | February 16, 2022 | September 20, 2022 | |
| NCT01861288 | Completed | Deep Endoscopic Remission Assessed by a Surrogate Biomarker in Patients With Inflammatory Bowel Disease | November 1, 2013 | February 28, 2018 | |
| NCT05180279 | Completed | N/A | The Impact of Circadian Misalignment on Colonic Barrier Homeostasis in Ulcerative Colitis | April 1, 2021 | June 1, 2024 |
| NCT05172557 | Completed | N/A | IBD and Women's Health Wellness Program | April 14, 2022 | December 26, 2023 |
| NCT01891214 | Completed | Validation of the French Version of the Inflammatory Bowel Disease Questionnaire (IBDQ) for Ulcerative Colitis and Crohn's Disease | December 2013 | January 2017 | |
| NCT01896635 | Completed | Phase 2 | Faecal Microbiota Transplantation in Ulcerative Colitis | November 2013 | August 2016 |
| NCT05171634 | Completed | N/A | Artificial Intelligence and Dysplasia Detection in Ulcerative Colitis (CUDISIA Study) | May 5, 2021 | May 18, 2021 |
| NCT01916161 | Completed | The Influence of Information Sources on Knowledge and Anxiety in Inflammatory Bowel Disease Patients | October 2013 | February 2016 | |
| NCT01929668 | Completed | N/A | Comparison of 4L Polyethylene Glycol and 2L Polyethylene Glycol With Ascorbic Acid in Inactive UC Patients | August 2013 | December 2014 |
| NCT01931644 | Completed | At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions | July 2013 | April 2024 | |
| NCT01941589 | Completed | Phase 4 | Corticosteroids+5-aminosalicylic Acid Compared to Corticosteroids in the Treatment of Moderate-severe Ulcerative Colitis | September 2013 | April 2021 |
| NCT01947101 | Completed | Phase 1 | Fecal Microbiota Transplantation (FMT) for Treatment of Ulcerative Colitis in Children | February 2014 | May 2016 |
| NCT01947816 | Completed | Special Investigation in Patients With Ulcerative Colitis | August 9, 2013 | February 15, 2018 | |
| NCT01959165 | Completed | Phase 2 | MEDI7183 Phase 2 Study in Japanese Ulcerative Colitis Patients | November 21, 2013 | April 10, 2018 |
| NCT01960439 | Completed | Responsiveness of Endoscopic Evaluation in UC | July 2013 | July 2015 | |
| NCT01966744 | Completed | Self-Management Assistance for Recommended Treatment (SMART) Portal | July 2013 | June 2016 | |
| NCT01988506 | Completed | Phase 2 | Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases | January 6, 2014 | April 1, 2021 |
| NCT01991314 | Completed | Phase 4 | Treatment of Iron Deficiency Anaemia in Inflammatory Bowel Disease With Ferrous Sulphate | December 2011 | June 2015 |
| NCT02020382 | Completed | N/A | Evaluation of the Diagnostic Value of microRNAs for Inflammatory Bowel Diseases | December 2013 | December 2017 |
| NCT02025777 | Completed | N/A | Evaluation of PillCam IBD Capsule Endoscopy System in Visualization of Lesions in the Colon Indicative of Ulcerative Colitis Disease | May 2014 | June 2015 |
| NCT02039505 | Completed | Phase 3 | Phase III Study of MLN0002 (300 mg) in the Treatment of Ulcerative Colitis | February 4, 2014 | June 28, 2018 |
| NCT02054533 | Completed | Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease | February 2014 | June 30, 2017 | |
| NCT02057016 | Completed | Long-term Scheduled Therapy With Infliximab in Inflammatory Bowel Disease | February 2014 | December 2014 | |
| NCT05098600 | Completed | The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic | October 15, 2021 | December 20, 2022 | |
| NCT02065089 | Completed | N/A | Development of 'Emma'--a Pediatric IBD Quiz | February 6, 2014 | January 5, 2017 |
| NCT02065557 | Completed | Phase 3 | Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitis | October 13, 2014 | February 7, 2020 |
| NCT05088369 | Completed | Phase 1 | Assessment of the Safety, Tolerability, and Pharmacokinetic of HM201 | November 11, 2021 | December 19, 2022 |
| NCT02069561 | Completed | N/A | Effects of Eicosapentaenoic Acid on Subjects at High Risk for Colorectal Cancer | January 2014 | |
| NCT02073526 | Completed | Anti-TNF-alpha Trough Level Measurements in Inflammatory Bowel Disease | May 2013 | November 2016 | |
| NCT02084186 | Completed | N/A | Moxibustion for Mild and Moderate Ulcerative Colitis | March 2014 | December 2015 |
| NCT05084261 | Completed | Phase 1 | An Investigation of Oral BT051 in Subjects With Moderately to Severely Active Ulcerative Colitis (UC) | November 30, 2021 | November 30, 2022 |
| NCT02092285 | Completed | Phase 4 | Golimumab Utilization and Impact on Ulcerative Colitis (MK-8259-032) | May 9, 2014 | May 25, 2016 |
| NCT02093663 | Completed | Phase 3 | Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative Colitis | December 12, 2014 | November 28, 2018 |
| NCT02093767 | Completed | N/A | Oligofructose-enriched Inulin for the Treatment of Mild to Moderate Active Ulcerative Colitis | August 2007 | December 2011 |
| NCT02093780 | Completed | N/A | Personalized "Alberta" Diet for Prevention of Relapse in Ulcerative Colitis | March 2014 | October 2017 |
| NCT02100696 | Completed | Phase 3 | A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors | May 21, 2014 | April 16, 2020 |
| NCT02110862 | Completed | Scintigraphic Evaluation of IPAA Function in Patients With Ulcerative Colitis | January 2012 | August 2013 | |
| NCT05082428 | Completed | This Study is to Describe and Evaluate Patients in Finland Treated With Tofacitinib for the Treatment of Ulcerative Colitis Using Real World Data. | May 30, 2022 | November 1, 2022 | |
| NCT02120391 | Completed | N/A | Improving Knowledge of Medication in Ulcerative Colitis With an Iphone Application | February 2014 | December 2017 |
| NCT05061446 | Completed | Phase 2 | Etrasimod Dose-Ranging Versus Placebo as Induction Therapy Study in Adult Japanese Subjects With Moderately to Severely Active Ulcerative Colitis | September 10, 2021 | October 6, 2023 |
| NCT05051943 | Completed | A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response | September 29, 2020 | January 20, 2023 | |
| NCT02131168 | Completed | Epidemiology of IBD in Hong Kong: An Inception Cohort and Follow up Study | January 2011 | March 2021 | |
| NCT02135289 | Completed | The Role of IGRA in Screening and Monitoring for TB During Anti TNF Therapy in Patients With IMID | March 2012 | July 31, 2019 | |
| NCT02136069 | Completed | Phase 3 | A Study Comparing the Efficacy and Safety of Etrolizumab to Infliximab in Participants With Moderate to Severe Ulcerative Colitis Who Are Naïve to Tumor Necrosis Factor (TNF) Inhibitors | December 24, 2014 | June 23, 2020 |
| NCT02138318 | Completed | N/A | High Definition Versus Chromoendoscopy for Dysplasia Detection in Ulcerative Colitis (UC) | May 1, 2012 | September 19, 2015 |
| NCT04990245 | Completed | pAtient rePorted Outcomes Linked With histoLogy in Patients With uLcerative cOlitis | July 1, 2020 | July 28, 2021 | |
| NCT02148640 | Completed | Phase 4 | The NOR-SWITCH Study | October 2014 | January 2017 |
| NCT02149043 | Completed | Thermography in Surveillance of Ulcerative Colitis | January 2015 | June 2018 | |
| NCT02155335 | Completed | Phase 4 | Preference for a Prefilled Syringe or Smartject™ Device for Delivering Golimumab in Participants Suffering From Moderate-to-severe Ulcerative Colitis (MK-8259-027) | July 1, 2014 | October 5, 2015 |
| NCT02161640 | Completed | Vascular Dysfunction in Paediatric IBD | September 2014 | January 2017 | |
| NCT02163759 | Completed | Phase 3 | A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors | November 4, 2014 | March 19, 2020 |
| NCT02171429 | Completed | Phase 3 | A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors | November 14, 2014 | May 25, 2020 |
| NCT02179372 | Completed | N/A | Eicosapentaenoic Free Fatty Acid and Fecal Calprotectin in Inflammatory Bowel Diseases | June 2014 | November 2016 |
| NCT04969679 | Completed | Phase 4 | Additive Effect of Probiotics (Mutaflor®) in Patients With Ulcerative Colitis on 5-ASA Treatment. | March 16, 2018 | June 3, 2020 |
| NCT04963725 | Completed | A Study of Symptom Improvement of Ulcerative Colitis After an Induction Dose of Ustekinumab in Japanese Clinical Practice | July 18, 2021 | December 1, 2022 | |
| NCT02197780 | Completed | Head-to-head Comparison of Two Fecal Biomarkers to Screen Children for IBD | September 2014 | April 2017 | |
| NCT02200445 | Completed | Phase 1 | Low Dose IL-2 for Ulcerative Colitis | February 2015 | March 2021 |
| NCT02209987 | Completed | Phase 1 | Absolute Bioavailability, Safety, and Tolerability of Subcutaneous GS-5745 in Healthy Adults | August 2014 | October 2014 |
| NCT02213835 | Completed | N/A | Treatment With the Specific Carbohydrate Diet for Children With Active Crohns Disease and Ulcerative Colitis | June 2014 | September 2017 |
| NCT02227342 | Completed | Phase 1/Phase 2 | Fecal Microbiota Transplantation (FMT) in the Management of Active Ulcerative Colitis | July 2014 | December 2016 |
| NCT02227602 | Completed | N/A | Anti-Inflammatory Effects of Mango Polyphenolics in Inflammatory Bowel Disease | January 2014 | March 2018 |
| NCT02261636 | Completed | Induction and Maintenance of Remission With Pentasa as Ulcerative Colitis Treatment | January 2015 | January 14, 2019 | |
| NCT04933162 | Completed | N/A | UC Cohort - The Influence of Diet on Gut Microbiotas | August 3, 2021 | February 17, 2023 |
| NCT02265588 | Completed | N/A | Healthy Approach to Physical and Psychological Problems in Youngsters With IBD (HAPPY-IBD). | September 2014 | August 24, 2017 |
| NCT04924543 | Completed | N/A | OPtical Diagnosis Training to Improve Dysplasia Characterisation in IBD | July 7, 2021 | April 30, 2022 |
| NCT02267694 | Completed | Phase 1 | Study of Freeze-dried Black Raspberry in Maintenance of Ulcerative Colitis | August 2013 | November 13, 2015 |
| NCT02274714 | Completed | Dysmenorrhea in Women With Crohn's Disease and Ulcerative Colitis | May 2010 | January 2017 | |
| NCT04924114 | Completed | Phase 1 | A Study of MK-6194 (PT101) in Participants With Active Ulcerative Colitis (UC) (MK-6194-002) | October 14, 2021 | May 14, 2024 |
| NCT04909359 | Completed | Characterization of CD Responders to Vedolizumab | August 25, 2015 | May 18, 2020 | |
| NCT02280629 | Completed | Phase 3 | Phosphatidylcholine (LT-02) vs. Placebo vs. Mesalamine for Maintenance of Remission in Ulcerative Colitis (PROTECT-2) | October 1, 2014 | October 5, 2018 |
| NCT02289417 | Completed | Phase 2 | Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis | January 8, 2015 | June 3, 2019 |
| NCT02306772 | Completed | Phase 1 | TP0501 - Pharmaco-Scintigraphic-Study | December 2011 | March 2012 |
| NCT02306785 | Completed | Phase 1 | TP0502-Pharmaco-Scintigraphic-Study and Amendment | October 2012 | June 2013 |
| NCT02306798 | Completed | Phase 1 | TP0502-B-Pharmaco-Scintigraphic-Study | September 2013 | December 2013 |
| NCT00036439 | Completed | Phase 3 | A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Active Ulcerative Colitis | February 2002 | January 2007 |
| NCT02319798 | Completed | N/A | Telephone Consultation as a Substitute for Routine Out-patient Face-to-face Consultation for Children With Inflammatory Bowel Disease | July 2010 | January 2014 |
| NCT02322008 | Completed | Anti-TNF Therapy in Danish Patients With Inflammatory Bowel Diseases in Clinical Practice | September 2009 | March 2011 | |
| NCT02322307 | Completed | N/A | Trial on Impact of HealthPROMISE Mobile App on Inflammatory Bowel Disease Care and Quality of Life | February 2015 | January 20, 2020 |
| NCT04877990 | Completed | Phase 2 | A Study to Evaluate the Long-term Safety and Efficacy of Deucravacitinib in Participants With Crohn's Disease or Ulcerative Colitis | May 7, 2021 | August 29, 2023 |
| NCT02330653 | Completed | Phase 1/Phase 2 | Fecal Microbiota Transplant (FMT) in Pediatric Active Ulcerative Colitis and Pediatric Active Crohn's Colitis | November 2015 | April 8, 2019 |
| NCT04862741 | Completed | Phase 1 | Safety, Tolerability, and Pharmacokinetics of Oral NX-13 in Active Ulcerative Colitis | May 5, 2021 | October 5, 2022 |
| NCT02337608 | Completed | Phase 2 | Efficacy and Safety of GLPG1205 in Subjects With Active Ulcerative Colitis | December 2014 | November 2015 |
| NCT04861597 | Completed | N/A | Digital Behavioral Interventions in Inflammatory Bowel Disease | November 1, 2021 | March 22, 2023 |
| NCT02365480 | Completed | Phase 1 | Berberine Chloride in Preventing Colorectal Cancer in Patients With Ulcerative Colitis in Remission | June 16, 2016 | December 13, 2019 |
| NCT02368717 | Completed | Phase 3 | An Efficacy and Safety Study of PENTASA in Chinese Patients With Left-sided Active Ulcerative Colitis Followed by a 24-Week Open-Label Extension Phase | March 2015 | July 25, 2017 |
| NCT02370056 | Completed | N/A | Evaluation of 3D Visualization for Total Colectomy | March 2015 | May 17, 2019 |
| NCT04852666 | Completed | Comparative Effectiveness of Biologics or Small Molecule Therapies in Inflammatory Bowel Disease (IBD) | July 25, 2019 | December 15, 2022 | |
| NCT02423460 | Completed | N/A | Threonine Requirement in IBD Adults and Healthy Adult Controls | May 2015 | September 23, 2018 |
| NCT02423512 | Completed | The Impact of Anti-TNF Exposure on Vedolizumab Effectiveness | June 2015 | June 13, 2017 | |
| NCT02425852 | Completed | Phase 4 | A Randomized, Multicenter Open Label Study Comparing Early Administration of Azathioprine Plus IFX to Steroids Plus Azathioprine for Acute Severe Colitis | December 2016 | January 2023 |
| NCT02425865 | Completed | Phase 4 | Intensive Treatment to Reach the Target With Golimumab in ulcErative coliTis - In-TARGET | December 2016 | January 2023 |
| NCT02426372 | Completed | Phase 2 | Safety and Efficacy of QBECO in Moderate to Severe Ulcerative Colitis | July 2015 | December 2016 |
| NCT02435992 | Completed | Phase 3 | Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis | June 17, 2015 | June 17, 2020 |
| NCT02439372 | Completed | Assessment of CMV-specific ELISPOT Assay for Predicting CMV Colitis in Patient With Ulcerative Colitis | April 2015 | June 2016 | |
| NCT04828031 | Completed | Phase 1 | Vitamin D Regulation of Gut Specific B Cells and Antibodies Targeting Gut Bacteria in Inflammatory Bowel Disease | July 1, 2021 | July 1, 2023 |
| NCT02442960 | Completed | Phase 1 | Evaluating Safety and Efficacy of Herbal Treatment in Ulcerative Colitis | December 2014 | July 26, 2017 |
| NCT02447302 | Completed | Phase 2 | Safety and Efficacy of Etrasimod (APD334) in Patients With Ulcerative Colitis | October 15, 2015 | February 14, 2018 |
| NCT02463045 | Completed | Phase 1 | Study for Safety and Tolerability of TOP1288 Administered Rectally in Healthy and Ulcerative Colitis Subjects | May 2015 | July 2016 |
| NCT02465385 | Completed | Phase 4 | Single-dose Linaclotide for Capsule Endoscopy Preparation | February 2015 | June 2016 |
| NCT02469220 | Completed | N/A | Diet Treatment of Patients With Ulcerative Colitis in Remission | July 1, 2018 | April 26, 2022 |
| NCT04820413 | Completed | N/A | Faecal Microbiota Transplantation From Normal Pouch Function Donor in the Treatment of Chronic Pouchitis | March 1, 2021 | March 15, 2022 |
| NCT04804540 | Completed | Phase 4 | A Study of Vedolizumab in People With Ulcerative Colitis and Crohn's Disease | December 29, 2021 | February 2, 2024 |
| NCT02487238 | Completed | Phase 1 | Pediatric FEcal Microbiota Transplant for Ulcerative Colitis | November 2015 | December 2018 |
| NCT02499263 | Completed | A Prospective Non-interventional Multicenter Study to Evaluate the Effectiveness of Adalimumab in Korean Patients With Ulcerative Colitis (UC) and Identify Potential Predictors of Clinical Response in Routine Clinical Practice | June 11, 2015 | September 17, 2018 | |
| NCT02502552 | Completed | Study of Anti-glycan Antibodies Stability in Saint-Etienne IBD Cohort | November 2013 | October 2015 | |
| NCT02503514 | Completed | Autoimmune Paradoxical Reactions in IBD Longitudinal Cohort | August 2015 | August 2017 | |
| NCT02506179 | Completed | Impact of Adalimumab on Patient-reported Outcomes in Ulcerative Colitis | August 18, 2015 | February 10, 2020 | |
| NCT02508012 | Completed | N/A | Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF-α Agents in Inflammatory Bowel Diseases | September 24, 2015 | January 1, 2020 |
| NCT02516384 | Completed | Phase 1 | Fecal Microbiota Transplantation (FMT) in the Management of Ulcerative Colitis (UC) | October 1, 2016 | January 31, 2017 |
| NCT04775732 | Completed | Phase 4 | Ultra-proactive Therapeutic Drug Monitoring in Inflammatory Bowel Disease | June 1, 2018 | September 30, 2019 |
| NCT02522767 | Completed | Phase 3 | Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC) | October 2015 | April 3, 2018 |
| NCT02522780 | Completed | Phase 3 | Mesalamine 2 g Sachet for the Maintenance of Clinical and Endoscopic Remission in Ulcerative Colitis (UC) | February 1, 2016 | September 19, 2018 |
| NCT02536404 | Completed | Phase 2 | Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis | January 25, 2016 | November 1, 2018 |
| NCT02539368 | Completed | Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Inflammatory Bowel Disease | April 22, 2015 | October 31, 2018 | |
| NCT02542917 | Completed | Home Versus Postal Testing for Faecal Calprotectin: a Feasibility Study | September 2015 | August 2016 | |
| NCT02550158 | Completed | N/A | A Study Evaluating the Impact of an Educational Program (EDU-MICI) on Patients With Inflammatory Bowel Disease | June 2011 | April 2015 |
| NCT04757935 | Completed | N/A | Yoga for Youth With IBD: a Pilot Feasibility Study | January 1, 2017 | May 31, 2017 |
| NCT04719169 | Completed | N/A | MRI Anastomotic Integrity of Pelvic Intestinal Anastomoses | June 13, 2017 | February 24, 2020 |
| NCT02586259 | Completed | Effectiveness of Cortiment® in Patients With Ulcerative Colitis | December 2015 | April 5, 2018 | |
| NCT02589665 | Completed | Phase 2 | A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Ulcerative Colitis | December 9, 2015 | May 7, 2019 |
| NCT02606032 | Completed | Phase 2 | Trial of Antimicrobials Versus Placebo in Addition to Fecal Transplant Therapy in Ulcerative Colitis | May 2016 | January 27, 2021 |
| NCT04706793 | Completed | Phase 3 | Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN) | December 25, 2020 | August 3, 2022 |
| NCT02618187 | Completed | Phase 1 | A Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects With Mild-to-Moderate Ulcerative Colitis | January 13, 2016 | January 26, 2018 |
| NCT02620514 | Completed | N/A | Medication Adherence in Patients With Inflammatory Bowel Disease (IBD) | June 2015 | November 1, 2016 |
| NCT02622139 | Completed | N/A | Multispectral Optoacoustic Tomography (MSOT) for the Evaluation of Disease Activity in Inflammatory Bowel Diseases (IBD) | November 2015 | December 2019 |
| NCT02640391 | Completed | Predictive Factors of Endoscopic Mucosal Healing in Quiescent Ulcerative Colitis | January 2016 | December 2018 | |
| NCT02647866 | Completed | Phase 2 | Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis | June 2016 | October 2018 |
| NCT02665845 | Completed | Phase 3 | Combination Corticosteroids+5-aminosalicylic Acids Compared to Corticosteroids Alone (for Ulcerative Colitis). | June 13, 2016 | May 11, 2021 |
| NCT04691232 | Completed | Phase 1 | Autologous Ex Vivo Expanded Regulatory T Cells in Ulcerative Colitis | February 22, 2021 | May 22, 2023 |
| NCT04650867 | Completed | Non Invasive Characterization of Pediatric Inflammatory Bowel Diseases Using Multispectral Optoacoustic Tomography | March 22, 2021 | December 20, 2022 | |
| NCT02684734 | Completed | Prevalence of Cytomegalovirus Infection in Patients With Quiescent Ulcerative Colitis | December 2015 | December 2019 | |
| NCT02693730 | Completed | Phenotyping IBS: Perceptions and Modulations of Visceral Sensations | January 2016 | June 2021 | |
| NCT02717897 | Completed | Vitamin D and Disease Activity in Ulcerative Colitis | November 2011 | May 2013 | |
| NCT04637399 | Completed | Circadian Misalignment in Inflammatory Bowel Disease | November 22, 2016 | November 2021 | |
| NCT02735941 | Completed | Study on Cannabinoid Receptor Expression in Gastrointestinal Diseases | June 13, 2017 | July 27, 2018 | |
| NCT02742597 | Completed | N/A | Patient-Centred Innovations for Persons With Multimorbidity - Ontario | January 12, 2016 | October 19, 2022 |
| NCT02745457 | Completed | Body Composition in Children With Inflammatory Bowel Disease | April 2016 | July 31, 2023 | |
| NCT02749630 | Completed | Phase 1 | A Safety Study of Intravenously Administered UTTR1147A in Healthy Volunteers (HVs), Participants With Ulcerative Colitis (UC), and Participants With Crohn's Disease (CD) | April 11, 2016 | February 19, 2020 |
| NCT02750800 | Completed | Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie's Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary (VALUE) | April 7, 2016 | April 3, 2018 | |
| NCT04596293 | Completed | Phase 2 | Efficacy and Safety of Orally Administered BBT-401-1S in Subjects With Ulcerative Colitis | June 11, 2021 | July 12, 2022 |
| NCT02770040 | Completed | Phase 4 | Optimising Infliximab Induction Therapy for Acute Severe Ulcerative Colitis | July 18, 2016 | September 7, 2022 |
| NCT02789800 | Completed | N/A | Patient-Centred Innovations for Persons With Multimorbidity - Quebec | April 22, 2016 | November 1, 2022 |
| NCT04577794 | Completed | Phase 2 | A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 6 Weeks in Adults With Ulcerative Colitis | October 5, 2020 | May 31, 2021 |
| NCT02818543 | Completed | Phase 1 | Safety and Pharmacokinetic Study of LYC-30937 in Subjects With Active Ulcerative Colitis | March 2016 | June 2016 |
| NCT02822352 | Completed | N/A | RCT: HDWL vs Virtual Chromoendoscopy in the Detection of Intraepithelial Neoplasia in Longstanding Colitis | August 2016 | August 7, 2018 |
| NCT02846961 | Completed | Anti CT-P13 Antibody in Moderate to Severe Inflammatory Bowel Disease | July 2016 | December 2020 | |
| NCT04564638 | Completed | Long-term Outcome of Patients With Acute Ulcerative Colitis After First Course of Intravenous Corticosteroids | March 1, 2015 | September 1, 2019 | |
| NCT02862132 | Completed | N/A | Predicting Response to Vedolizumab in Pediatric Inflammatory Bowel Diseases | January 2017 | January 2022 |
| NCT02865707 | Completed | N/A | Ulcerative Colitis Relapse Prevention by Prebiotics | August 2016 | December 2020 |
| NCT02868398 | Completed | Efficacy of Golimumab in Maintaining Deep Remission in UC Patients in Prolonged Remission With Infliximab | June 2016 | April 2020 | |
| NCT02888379 | Completed | Phase 2 | Phase 2a Study to Evaluate the Safety/Tolerability and Efficacy of TOP1288 200 mg Rectal Solution Once Daily for 4 Weeks in Ulcerative Colitis | September 2016 | June 28, 2017 |
| NCT04508413 | Completed | N/A | A Clinical Study to Assess the Effects of KB295 in Patients With Ulcerative Colitis (UC) on Gut Microbiota Structure and Function | August 12, 2020 | November 29, 2021 |
| NCT04505410 | Completed | Phase 3 | Second Line Induction Therapy and Healthy Diet for Patients With Ulcerative Colitis | September 18, 2020 | December 7, 2023 |
| NCT04499495 | Completed | Assessment of 5-Aminosalicylic Acid Prescription Patterns and Treatment Outcomes in Patients With Ulcerative Colitis in Korea | October 25, 2021 | July 31, 2022 | |
| NCT02914522 | Completed | Phase 3 | Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis | November 14, 2016 | March 31, 2020 |
| NCT04474561 | Completed | N/A | Reduced Sulfur Diet in Ulcerative Colitis Patients | April 20, 2016 | March 30, 2021 |
| NCT02921555 | Completed | Phase 4 | Endovenous Corticosteroid Pulses in Moderate Ulcerative Colitis | October 11, 2018 | November 7, 2022 |
| NCT02922881 | Completed | N/A | Microbiota-targeted Diet for Pediatric UC | March 8, 2017 | September 30, 2021 |
| NCT02925338 | Completed | National Observational Study On The Use Of Inflectra™ An Infliximab Biosimilar In Real Life | October 19, 2016 | April 12, 2021 | |
| NCT02931162 | Completed | N/A | The Effects of Moxibustion on Ulcerative Colitis | August 23, 2016 | December 31, 2019 |
| NCT04458805 | Completed | Phase 1 | Safety, Tolerability and Pharmacokinetics of Oral NX-13 in Healthy Adults Male and Female Volunteers | July 10, 2020 | October 21, 2020 |
| NCT02958865 | Completed | Phase 2 | Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis | February 3, 2017 | May 10, 2021 |
| NCT04388865 | Completed | N/A | Patient Automated Text Hovering for IBD | February 23, 2021 | January 10, 2023 |
| NCT02994836 | Completed | Phase 4 | GIS-SUSANTI-TNF-2015 (Anti-TNF Discontinuation ) | April 21, 2017 | December 31, 2022 |
| NCT04360343 | Completed | Phase 1 | Compare the Pharmacokinetics, Pharmacodynamics and Safety/Tolerability of LC51-0255 Film-coated Tablet (SG85) With LC51-0255 Uncoated Tablet (SG82) in Healthy Subjects | July 1, 2020 | December 1, 2020 |
| NCT03006809 | Completed | Phase 1 | Optimal Fecal Microbiota Transplant Dosing for Mild to Moderate Ulcerative Colitis | March 2, 2017 | April 4, 2021 |
| NCT03011593 | Completed | N/A | Effect of UGIR in Adults With Compromised Gut Function and Malabsorption | November 2015 | June 2016 |
| NCT03018925 | Completed | Golimumab Effect in the Modulation of Gut Microbiota in Ulcerative Colitis | October 2016 | October 2020 | |
| NCT03038711 | Completed | Phase 1 | A Multiple Dose Study to Assess the Safety and Tolerability of BMS-986166 in Healthy Volunteers | February 1, 2017 | August 10, 2017 |
| NCT03051204 | Completed | OptiCal Study -Optimizing Fecal Calprotectin Monitoring: a Clinical Study Comparing CalproLab Against PhiCal and Evaluating Its Association With the Gut Microbiome | February 28, 2017 | December 11, 2018 | |
| NCT03053713 | Completed | N/A | The Effect of Diet on Disease Activity and Symptoms in Patients With Ulcerative Colitis | April 4, 2017 | August 30, 2021 |
| NCT04276649 | Completed | A Retrospective Analysis: the Influence of Caltrate Supplement on the Effect of Mesalazine in Ulcerative Colitis | January 1, 2015 | March 31, 2021 | |
| NCT03071081 | Completed | Phase 1 | Study for Safety and Tolerability of TOP1288 Administered Orally in Healthy Subjects | February 8, 2017 | June 2, 2017 |
| NCT03074656 | Completed | N/A | The Norwegian Drug Monitoring Study | March 1, 2017 | December 14, 2020 |
| NCT03079700 | Completed | Immune Modulation From Trichuris Suis | August 1, 2012 | December 31, 2012 | |
| NCT04241029 | Completed | N/A | Boosting Biologics in UC | February 25, 2020 | December 15, 2023 |
| NCT03093259 | Completed | Phase 2 | ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis | November 16, 2017 | February 4, 2019 |
| NCT03104036 | Completed | Phase 2 | Faecal Bacteriotherapy for Ulcerative Colitis | June 19, 2017 | June 30, 2021 |
| NCT04239521 | Completed | The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata | October 1, 2020 | November 28, 2022 | |
| NCT03124121 | Completed | Phase 4 | Study of the Golimumab Exposure-Response Relationship Using Serum Trough Levels | September 5, 2017 | September 30, 2019 |
| NCT04224857 | Completed | Phase 1 | SAD/MAD Study in Healthy Subjects and Adults With UC to Evaluate Safety, Tolerability, PK, PD of AMT-101 | April 1, 2019 | April 30, 2020 |
| NCT04223479 | Completed | Phase 2/Phase 3 | Effect of Probiotic Supplementation on the Immune System in Patients With Ulcerative Colitis in Amman, Jordan | January 15, 2020 | March 10, 2022 |
| NCT03138655 | Completed | Phase 2 | Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) | November 8, 2017 | May 26, 2020 |
| NCT03142113 | Completed | Clinical Outcome After Escalation and De-escalation of Adalimumab in Real Life in Ulcerative Colitis | November 2016 | May 2017 | |
| NCT03143517 | Completed | Fecal Calprotectin Collection Protocol | April 19, 2017 | August 23, 2018 | |
| NCT02791854 | Enrolling by invitation | Improving the Quality of Care for Adults With Inflammatory Bowel Disease | February 26, 2016 | December 2030 | |
| NCT04835506 | Enrolling by invitation | Phase 4 | Proactive Infliximab Optimization Using a Pharmacokinetic Dashboard Versus Standard of Care in Patients With Inflammatory Bowel Disease: The OPTIMIZE Trial | November 1, 2021 | December 31, 2024 |
| NCT04191655 | Enrolling by invitation | N/A | High Definition Colonoscopy (HDC) vs. Dye Spraying Chromo-colonoscopy (DSC) in Screening Patients With Long-standing Inflammatory Bowel Disease (IBD) | April 3, 2019 | December 2025 |
| NCT05994716 | Enrolling by invitation | N/A | Telemonitoring for IBD Goodness Examination in Russia | April 25, 2023 | October 30, 2024 |
| NCT06381518 | Enrolling by invitation | N/A | Switching From Intravenous to Subcutaneous Infliximab in Adult Patients With Inflammatory Bowel Disease | March 12, 2024 | May 1, 2025 |
| NCT06067698 | Not yet recruiting | N/A | Alpha Lipoic Acid in Ulcerative Colitis | October 1, 2023 | October 1, 2024 |
| NCT06306261 | Not yet recruiting | Controlling the Mental Health for a Better Response to Treatment in Patients With Ulcerative Colitis | March 15, 2024 | March 15, 2025 | |
| NCT05606939 | Not yet recruiting | The Role of Intestinal Ultrasound in Monitoring the Response to Biological Therapy in Patients With Ulcerative Colitis | January 1, 2023 | March 12, 2024 | |
| NCT06405087 | Not yet recruiting | Phase 3 | A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD) | December 2, 2024 | January 26, 2032 |
| NCT05117749 | Not yet recruiting | Phase 2 | Saffron and Ulcerative Colitis | May 2023 | August 2025 |
| NCT06331637 | Not yet recruiting | Outcomes of Transanal Tran-section and Single-stapled (TTSS) Ileal Pouch-Anal Anastomosis | July 31, 2024 | December 31, 2026 | |
| NCT05112263 | Not yet recruiting | N/A | Tofacitinib Versus Cyclosporine for Steroid Refractory Acute Severe Ulcerative Colitis | July 1, 2023 | June 1, 2026 |
| NCT06449820 | Not yet recruiting | Janus Kinase Inhibitors for the Treatment of Acute Severe Ulcerative Colitis | May 30, 2024 | June 30, 2024 | |
| NCT05976802 | Not yet recruiting | Phase 4 | Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Rectal Foam in Pediatric Patients Aged 5 to 17 Years With Active, Mild to Moderate Distal Ulcerative Colitis | June 2024 | June 2025 |
| NCT05579483 | Not yet recruiting | N/A | Prediction of Dietary Intervention Efficacy in Mild Ulcerative Colitis Patients Based on Fecal Microbiome Signatures | December 2023 | October 2025 |
| NCT05771155 | Not yet recruiting | Phase 3 | Efficacy, Safety and Immunogenicity of the Proposed Biosimilar Vedolizumab PB016 in Comparison With Entyvio® | May 2023 | September 2025 |
| NCT05539625 | Not yet recruiting | Phase 2 | Mini-MARVEL - Mitochondrial Antioxidant Therapy in Ulcerative Colitis | September 2022 | October 2024 |
| NCT05719766 | Not yet recruiting | N/A | Effect of Incentive Integrated E-IBD Chronic Disease Management Model on the Quality of Life in IBD Patients | April 1, 2023 | February 1, 2027 |
| NCT06120322 | Not yet recruiting | Machine Learning Approach to Study the Interactions Between Environment and Intestinal Tissue Homeostasis in IBD | November 1, 2023 | November 1, 2025 | |
| NCT06439641 | Not yet recruiting | N/A | Prevalence and Factors Associated With Sleep Disorders in Inflammatory Bowel Disease | July 2024 | September 2025 |
| NCT05486507 | Not yet recruiting | N/A | Health Benefits of Tart Cherry in Ulcerative Colitis | July 1, 2023 | June 1, 2024 |
| NCT05482932 | Not yet recruiting | Health-related Physical Fitness in Patients With Inflammatory Bowel Disease | August 1, 2022 | April 1, 2024 | |
| NCT06315179 | Not yet recruiting | Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE) | April 2024 | January 2030 | |
| NCT04939025 | Not yet recruiting | N/A | Multi-interventional Program to Reduce Chronic Ileoanal Pouch Leaks in UC | July 1, 2021 | August 1, 2025 |
| NCT06126835 | Not yet recruiting | A Study to Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Ulcerative Colitis and Their Infants | August 1, 2024 | May 31, 2031 | |
| NCT05809583 | Not yet recruiting | Define Predictors of Response to Ozanimod in UC Discovering Biomarkers in the Management of Ulcerative Colitis | May 1, 2023 | April 1, 2024 | |
| NCT06352515 | Not yet recruiting | T Lymphocyte Subsets in Ulcerative Colitis | June 1, 2024 | June 1, 2027 | |
| NCT05715099 | Not yet recruiting | Phase 4 | Saffron as Anti Inflammatory In Patients With Inflammatory Bowel Disease | March 30, 2023 | July 30, 2023 |
| NCT05835973 | Not yet recruiting | N/A | Evaluation of Sleep Changes in Inflammatory Bowel Diseases (IBD) Patients. | May 1, 2024 | September 1, 2026 |
| NCT06335160 | Not yet recruiting | N/A | Possible Efficacy and Safety of Mebendazole in Patients With Ulcerative Colitis Treated With Mesalamine | April 2024 | May 2025 |
| NCT06453317 | Not yet recruiting | Phase 2 | Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis | July 2024 | June 30, 2028 |
| NCT06089590 | Not yet recruiting | Ibd CAncer and seRious Infections in France (I-CARE 2) | November 15, 2023 | March 1, 2031 | |
| NCT06459297 | Not yet recruiting | Study of Oral Upadacitinib to Assess Change in Disease Activity and Adverse Events in Adult Participants With Ulcerative Colitis or Crohn's Disease | June 30, 2024 | December 31, 2025 | |
| NCT05892159 | Not yet recruiting | N/A | Heart Rate Variability (HRV) Biofeedback to Treat Ulcerative Colitis | July 2024 | July 2025 |
| NCT06143163 | Not yet recruiting | Clinical Outcome of Treatment of Ulcerative Colitis in Adult | December 29, 2024 | January 29, 2026 | |
| NCT05698745 | Not yet recruiting | Immunological Characteristics of Preclinical IBD(EARLY) | May 1, 2024 | May 1, 2038 | |
| NCT06249763 | Not yet recruiting | N/A | Effects of Gluten Free Diet in Ulcerative Colitis | February 2024 | May 2025 |
| NCT06188637 | Not yet recruiting | Phase 4 | Ulcerative Colitis Leukocyte TRAfficking After Treatment With Zeposia: the ULTRAZ Study | March 1, 2024 | March 1, 2027 |
| NCT05689892 | Not yet recruiting | N/A | Shared Decision Making in Paediatric Inflammatory Bowel Disease | January 2024 | December 2025 |
| NCT06420492 | Not yet recruiting | Phase 2 | Study of Novel Therapeutics for Acute Remedy of Colitis | August 1, 2024 | December 1, 2025 |
| NCT05684484 | Not yet recruiting | Phase 4 | Role of Roflumilast in Ulcerative Colitis | February 1, 2023 | November 2024 |
| NCT06213857 | Not yet recruiting | N/A | Beneficial Effect of Silymarin in Ulcerative Colitis | February 2024 | March 2025 |
| NCT05907330 | Not yet recruiting | Phase 2 | Phase 2 Study of CU104 in Moderate-Severe Ulcerative Colitis | June 1, 2024 | March 31, 2026 |
| NCT05974332 | Not yet recruiting | N/A | Oncostatin M in Ulcerative Colitis Patients | August 1, 2023 | March 1, 2024 |
| NCT05663671 | Not yet recruiting | Evaluate Established Anti-DEFA5 mAbs Diagnostic Efficacy and Safety in IBD | June 1, 2023 | June 30, 2025 | |
| NCT04290156 | Not yet recruiting | N/A | The Effect of Joint Transition Visits on Quality of Life in Inflammatory Bowel Diseases (TRANS-IBD) | April 1, 2020 | November 1, 2024 |
| NCT06424769 | Not yet recruiting | N/A | Improving Outcomes and Reducing Disparities for Patients With Inflammatory Bowel Disease Through Epidemiology and Enhanced Disease Management | May 2024 | September 2028 |
| NCT06095128 | Not yet recruiting | Phase 4 | A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC) | May 31, 2024 | July 9, 2027 |
| NCT05743153 | Not yet recruiting | N/A | Feasibility of a Multimodal Intervention Program to Optimize Treatment Outcomes in Ulcerative Colitis | October 1, 2023 | October 1, 2024 |
| NCT05931458 | Not yet recruiting | N/A | AppenDectomy Vs ANti TNF-a in Inducing Clinical and EnDoscopic Remission in Left-sided Ulcerative Colitis | July 1, 2023 | July 1, 2028 |
| NCT06420375 | Not yet recruiting | Phase 2 | Treatment of UC With Novel Therapeutics | August 1, 2024 | December 31, 2025 |
| NCT06100289 | Not yet recruiting | Phase 3 | A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease | September 30, 2024 | June 30, 2027 |
| NCT06116643 | Not yet recruiting | Phase 1 | Pilot Study of a New Medical Food in the Management of Ulcerative Colitis | December 2023 | December 2025 |
| NCT06316999 | Not yet recruiting | N/A | Intestinal Ultrasound for the Evaluation of Pouchitis and Other Outcomes After Ileal Pouch-Anal Anastomosis | July 1, 2024 | June 2025 |
| NCT05737836 | Not yet recruiting | Analyzing the Factors in Ulcerative Colitis Patients' Clinical Trial Experiences | March 2024 | March 2026 | |
| NCT04999241 | Not yet recruiting | Phase 4 | Combined Application of EEN in the Induction of Remission in PUC | March 1, 2024 | December 31, 2026 |
| NCT05953402 | Not yet recruiting | A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring | September 6, 2023 | June 30, 2032 | |
| NCT06298461 | Not yet recruiting | Phase 4 | Bowel Preparation for Colonoscopy Among Individuals With Crohn's and Ulcerative Colitis Disease. | May 2024 | June 2025 |
| NCT05610956 | Not yet recruiting | Early Phase 1 | Evaluate the Possible Efficacy and Safety of Empagliflozin in Patient With Ulcerative Colitis | December 1, 2022 | December 1, 2026 |
| NCT06228352 | Not yet recruiting | Role of Bile Acids and Microbiota in Clostridioides Difficile Infection in Ulcerative Colitis | March 2024 | March 2027 | |
| NCT00001184 | Recruiting | Immune Regulation in Ulcerative Colitis or Crohn s Disease | August 7, 1998 | ||
| NCT01140789 | Recruiting | GWA Study in Patients With Inflammatory Bowel Disease | April 2010 | April 2037 | |
| NCT01731665 | Recruiting | Epidemiology of Inflammatory Bowel Disease in the Songpa-Kangdong District, Seoul, Korea. | December 2012 | June 2029 | |
| NCT01790061 | Recruiting | Phase 2/Phase 3 | Standardized Fecal Microbiota Transplantation for Ulcerative Colitis | February 2013 | December 2025 |
| NCT02308917 | Recruiting | The Canadian Children Inflammatory Bowel Disease Network (CIDsCaNN) | September 2013 | April 1, 2026 | |
| NCT02636517 | Recruiting | Phase 1 | Fecal Microbiome Transplant | December 2015 | December 2025 |
| NCT03251118 | Recruiting | A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease | July 24, 2017 | July 2025 | |
| NCT03483246 | Recruiting | Phase 3 | Impact of Fecal Microbiota Transplantation in Ulcerative Colitis | September 17, 2018 | December 24, 2026 |
| NCT03519945 | Recruiting | Phase 3 | A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3) | July 18, 2018 | December 20, 2027 |
| NCT03571373 | Recruiting | PIBD-SETQuality: the Inception Cohort and Safety Registry | January 3, 2017 | December 31, 2025 | |
| NCT03589183 | Recruiting | Gut Microbiome in Inflammatory Bowel Disease | April 1, 2018 | March 31, 2028 | |
| NCT03615690 | Recruiting | N/A | The Influence of a Fasting Mimicking Diet on Ulcerative Colitis | December 15, 2020 | December 2025 |
| NCT03669822 | Recruiting | Multi-center Acute Severe Ulcerative Colitis Cohort Study (MASCC) | November 10, 2018 | December 31, 2024 | |
| NCT03679546 | Recruiting | Phase 4 | EFFICACI : EFFicacy of Intravenous Infliximab Versus Vedolizumab After Failure of subCutaneous Anti-TNF in Patients With UlCerative Colitis | January 4, 2019 | January 4, 2025 |
| NCT03724175 | Recruiting | Phase 2/Phase 3 | The Role of Secondary Bile Acids in Intestinal Inflammation | August 26, 2019 | December 2050 |
| NCT03774329 | Recruiting | N/A | Impact of a Physical Activity Program on Bone Mineral Density in Children and Adolescents With Chronic Inflammatory Bowel Disease | March 2, 2020 | December 2023 |
| NCT03804931 | Recruiting | Phase 2/Phase 3 | Fecal Microbiota Transplantation for Ulcerative Colitis | January 20, 2019 | December 31, 2030 |
| NCT03809728 | Recruiting | N/A | IDENTIFICATION OF PROGNOSTIC AND PREDICTIVE BIOMARKERS IN INFLAMMATORY BOWEL DISEASE | December 10, 2019 | December 10, 2034 |
| NCT03816345 | Recruiting | Phase 1 | Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer | July 16, 2019 | August 31, 2024 |
| NCT03843385 | Recruiting | Phase 3 | Transfer of FRozen Encapsulated Multidonor Stool Filtrate for Active Ulcerative COlitis | January 31, 2023 | July 2026 |
| NCT03847467 | Recruiting | Phase 1/Phase 2 | Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy | September 20, 2019 | March 2027 |
| NCT03869905 | Recruiting | Phase 2 | Aquamin® as an Adjuvant Intervention for Ulcerative Colitis | August 8, 2019 | September 2026 |
| NCT03872271 | Recruiting | N/A | Is Diverting Loop Ileostomy Necessary in Completion Proctectomy With Ileal Pouch Anal- Anastomosis: A Multicentre, Randomized Study of the GETAID Chirurgie Group. IDEAL Trial | November 26, 2019 | May 24, 2025 |
| NCT03885713 | Recruiting | Phase 4 | Identification of Predictive Biomarkers for Response to Biologic Therapies and Tofacitinib in Inflammatory Bowel Disease | September 10, 2019 | December 31, 2024 |
| NCT03935451 | Recruiting | Early Phase 1 | Postoperative Extended Venous Thromboprophylaxis in Inflammatory Bowel Disease | September 1, 2021 | February 1, 2026 |
| NCT03944447 | Recruiting | Phase 2 | Outcomes Mandate National Integration With Cannabis as Medicine | December 1, 2018 | December 31, 2025 |
| NCT03950232 | Recruiting | Phase 3 | An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis | September 5, 2019 | July 21, 2026 |
| NCT04014413 | Recruiting | N/A | Safety and Efficacy of Fecal Microbiota Transplantation | July 15, 2019 | October 31, 2030 |
| NCT04060303 | Recruiting | Phase 3 | ENhanced Recovery in CHildren Undergoing Surgery | July 1, 2020 | December 31, 2024 |
| NCT04133194 | Recruiting | Phase 4 | Adherence of a 1.600 mg Single Tablet 5-ASA Treatment of Ulcerative Colitis | November 28, 2019 | March 1, 2025 |
| NCT04178408 | Recruiting | IBD Registry in a Sub-Saharan African Population | January 2, 2021 | December 31, 2025 | |
| NCT04183608 | Recruiting | Phase 4 | A Trial COmparing staNdard of Care Versus Treat to Target With telemonitoRing and Patient Education in Patients With Ulcerative cOlitis Initiating Adalimumab | January 14, 2020 | May 2028 |
| NCT04191395 | Recruiting | Evolution and Treatments of Chronic Inflammatory Systemic Diseases | December 11, 2019 | December 2029 | |
| NCT04223518 | Recruiting | Early Phase 1 | Serum Bovine Immunoglobulin (SBI) in Children and Young Adults With Inflammatory Bowel Disease (IBD) | September 20, 2020 | May 31, 2023 |
| NCT04231110 | Recruiting | Phase 4 | Combination Therapy With Fecal Microbiota Transplantation and Vedolizumab for Induction of Ulcerative Colitis | May 1, 2021 | December 30, 2024 |
| NCT04303260 | Recruiting | N/A | Special Physical Exercises as a Therapeutic Intervention for Inflammatory Bowel Disease | July 8, 2019 | December 2025 |
| NCT04312113 | Recruiting | Phase 1 | Angiographic Delivery of AD-MSC for Ulcerative Colitis | November 16, 2020 | December 2024 |
| NCT04314375 | Recruiting | Phase 4 | Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis | September 29, 2023 | December 2024 |
| NCT04331639 | Recruiting | Phase 2 | High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy | November 1, 2020 | September 2024 |
| NCT04338204 | Recruiting | Observational Study To Assess The Effectiveness and Treatment Adherence Of Tofacitinib of Ulcerative Colitis In Clinical Practice In Sweden | September 18, 2020 | August 14, 2026 | |
| NCT04401605 | Recruiting | N/A | Fermented Food-Supplemented Diet in Ulcerative Colitis | September 14, 2020 | June 2025 |
| NCT04424303 | Recruiting | Tofacitinib in Adult Patients With Moderate to Severe Ulcerative Colitis | December 4, 2020 | June 30, 2026 | |
| NCT04617184 | Recruiting | Registry and Biorepository for IBD in Central Texas | June 1, 2021 | December 31, 2030 | |
| NCT04624230 | Recruiting | Phase 3 | Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitis | August 12, 2021 | December 21, 2026 |
| NCT04663971 | Recruiting | Fertility and Pregnancy After Surgery IBD Audit | February 1, 2024 | October 1, 2024 | |
| NCT04687150 | Recruiting | N/A | Fecal Microbiota Transplantation and Newly Diagnosed Ulcerative Colitis (UC) | January 1, 2021 | March 2024 |
| NCT04722757 | Recruiting | N/A | Comparison of Functional Outcomes Between Transanal and Laparoscopic vs Open Ileal Pouch-Anal Anastomosis | January 1, 2021 | June 30, 2025 |
| NCT04738942 | Recruiting | Phase 3 | A Study of Intravenous Vedolizumab Administered Every 4 Weeks in Japanese Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease | June 4, 2021 | September 18, 2024 |
| NCT04743518 | Recruiting | N/A | Impact of Anti-TNF, Vedolizumab and Tofacitinib on Aortic Stiffness, Carotid Intima-media Thickness and Cardiovascular Risk of Patients With Ulcerative Colitis | February 2, 2021 | February 2024 |
| NCT04748627 | Recruiting | Global IBD Visualization of Epidemiology Studies (GIVES) in the 21st Century | October 1, 2021 | December 2023 | |
| NCT04751396 | Recruiting | Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors | April 20, 2022 | April 15, 2025 | |
| NCT04767984 | Recruiting | Phase 2 | Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis | September 24, 2021 | December 31, 2024 |
| NCT04827368 | Recruiting | Volatile Organic Compounds (VOCs) in Active Inflammatory Bowel Disease | March 22, 2021 | September 30, 2025 | |
| NCT04844606 | Recruiting | Phase 3 | A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON) | May 26, 2021 | July 30, 2030 |
| NCT04855799 | Recruiting | Phase 2 | GI Permeability Change in Response to Aquamin® | November 2, 2021 | January 2025 |
| NCT04883840 | Recruiting | Phase 2/Phase 3 | Drug Repurposing - Statins as Microbiota Modulating Agents in Ulcerative Colitis | October 22, 2020 | December 31, 2023 |
| NCT04897282 | Recruiting | Prospective Multicenter Trial to Determine the Efficacy and Outcome of the UCRI Biomarker Panel and Algorithm to Detect Mucosal Healing in Moderate to Severe Ulcerative Colitis Patients. | August 24, 2021 | December 31, 2024 | |
| NCT04908644 | Recruiting | N/A | MS-20 on Patients With Ulcerative Colitis(UC) | August 18, 2021 | November 30, 2024 |
| NCT04912999 | Recruiting | Inflammatory Bowel Diseases Remission Registry | August 1, 2019 | May 1, 2026 | |
| NCT04923100 | Recruiting | Therapeutic Effect of New Biologics in Crohn's Disease | June 10, 2021 | March 29, 2025 | |
| NCT04924270 | Recruiting | Phase 2 | Safety and Efficacy of Capsule FMT in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory Diseases | December 13, 2023 | December 31, 2026 |
| NCT04987307 | Recruiting | Phase 2 | Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis | January 31, 2022 | May 27, 2026 |
| NCT04998084 | Recruiting | Advanced Therapy Registry of IBD Patients | February 28, 2019 | June 27, 2025 | |
| NCT04999228 | Recruiting | Phase 4 | Top Down Versus Step up in Pediatric Ulcerative Colitis | November 1, 2021 | December 31, 2026 |
| NCT05019742 | Recruiting | Phase 2 | Evaluation of SPH3127 in Patients With Mild-to-Moderate Ulcerative Colitis | March 21, 2022 | December 2025 |
| NCT05058417 | Recruiting | Phase 2 | Assessment of Empagliflozin as Adjuvant Therapy in Patients With Ulcerative Colitis | October 1, 2021 | December 31, 2025 |
| NCT05069259 | Recruiting | Generate Real World Data On Tofacitinib Induction Therapy and Changes In Clinical and Patient Reported Outcomes. | March 28, 2022 | October 21, 2024 | |
| NCT05118919 | Recruiting | Phase 1/Phase 2 | A Safety Study of Lactobacillus Reuteri BGP-014 in Patients With Ulcerative Colitis | February 9, 2022 | December 2023 |
| NCT05176366 | Recruiting | Phase 1 | Study of ExoFlo for the Treatment of Medically Refractory Ulcerative Colitis | December 19, 2022 | September 1, 2024 |
| NCT05180175 | Recruiting | Phase 4 | The Nordic IBD Treatment Strategy Trial | February 7, 2022 | July 10, 2024 |
| NCT05181137 | Recruiting | Phase 3 | A Phase 3 Study to Investigate the Efficacy and Safety of SHR0302 With Moderately to Severely Active Ulcerative Colitis | November 5, 2021 | March 31, 2025 |
| NCT05186623 | Recruiting | Prediction Model for Response to Biologics and Small Molecular Agent for UC | February 5, 2022 | December 31, 2026 | |
| NCT05205603 | Recruiting | Phase 4 | Efficacy of Mesalazine Combined With Biologics in the Treatment of Moderate to Severe Ulcerative Colitis | January 15, 2022 | January 15, 2025 |
| NCT05213234 | Recruiting | N/A | Chronotherapy of 5-Aminosalicylic Acid in Ulcerative Colitis | July 9, 2021 | October 31, 2024 |
| NCT05218850 | Recruiting | Phase 1 | The Use of Butyrate Therapy in Pediatric Ulcerative Colitis | June 29, 2022 | June 30, 2027 |
| NCT05225545 | Recruiting | Phase 3 | Sucrosomial Iron vs. Oral Iron Sulfate for the Treatment of Iron Deficiency Anemia in Patients With Ulcerative Colitis | November 4, 2019 | May 4, 2024 |
| NCT05230173 | Recruiting | N/A | Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission | October 5, 2022 | June 1, 2028 |
| NCT05230875 | Recruiting | Sexual Dysfunction Among Inflammatory Bowel Disease Adults-Clinical Trial | April 7, 2022 | September 5, 2023 | |
| NCT05239702 | Recruiting | Early Phase 1 | Clinical Study of Targeting CD7 CAR-T Cells in the Treatment of Autoimmune Diseases | February 28, 2022 | December 1, 2024 |
| NCT05287126 | Recruiting | Phase 2 | A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis | December 16, 2022 | August 7, 2031 |
| NCT05313620 | Recruiting | Phase 4 | Effect of Tofacitinib on Coagulation and Platelet Function, and Its Role in Thromboembolic Events | April 1, 2022 | October 2024 |
| NCT05316584 | Recruiting | N/A | A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therapy | September 6, 2022 | December 31, 2024 |
| NCT05327790 | Recruiting | Phase 2 | LFMT vs Placebo in New Biologic Start for Ulcerative Colitis | June 3, 2022 | March 31, 2025 |
| NCT05370885 | Recruiting | Phase 2 | VE202 in Patients With Mild-to-Moderate Ulcerative Colitis | May 8, 2023 | November 10, 2025 |
| NCT05382897 | Recruiting | Early Phase 1 | Fasting-mimicking Diet in Treatment of Depressive Symptoms in IBD | July 1, 2022 | December 2024 |
| NCT05394272 | Recruiting | N/A | Efficacy of Energy Therapy in the Management of Chronic Pain Medical Condition in Children and Adolescents. | June 15, 2022 | June 16, 2025 |
| NCT05428345 | Recruiting | A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea | September 25, 2023 | November 30, 2027 | |
| NCT05430412 | Recruiting | N/A | CT to Assess the Efficacy and Safety of Adding GMA to Infliximab in Paediatric Patients With Steroid-refractory Ulcerative Colitis | January 11, 2022 | October 2024 |
| NCT05442567 | Recruiting | Phase 3 | A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD) | May 16, 2023 | August 15, 2031 |
| NCT05447572 | Recruiting | FIT Combining FC for Predicting MH and Histology Remission in UC | September 1, 2021 | December 12, 2023 | |
| NCT05456893 | Recruiting | A Study to Evaluate Biomarkers in Moderate to Severe Ulcerative Colitis (UC) Patients Treated With Different Targeted Therapies | July 28, 2022 | September 9, 2027 | |
| NCT05466890 | Recruiting | Phase 2 | Phase 2a To Evaluate PL-8177 in Subjects With Active Ulcerative Colitis (UC) | September 15, 2022 | August 30, 2024 |
| NCT05479617 | Recruiting | Personalised Prediction Of Disease Course In Ulcerative Colitis Using Multimodal Machine Learning - Part Of The Presager Project | June 20, 2022 | December 30, 2025 | |
| NCT05481619 | Recruiting | Phase 4 | Study of the Effect of Vedolizumab on Intestinal Microecological Changes and Its Efficacy in the Treatment of Ulcerative Colitis | January 1, 2021 | January 1, 2024 |
| NCT05488041 | Recruiting | N/A | Anal Manometry Examination in Patients With Ulcerative Colitis | June 1, 2022 | December 2023 |
| NCT05494606 | Recruiting | An Observational Study to Assess Change in Disease Activity and Adverse Events of Upadacitinib in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Real-World Practice | August 15, 2022 | March 31, 2028 | |
| NCT05496348 | Recruiting | Study of Oral Upadacitinib to Assess Change in Disease Activity in Adult Participants With Ulcerative Colitis | October 20, 2022 | August 16, 2027 | |
| NCT05507203 | Recruiting | Phase 3 | ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1 | October 10, 2022 | February 2025 |
| NCT05507216 | Recruiting | Phase 3 | ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2 | December 21, 2022 | February 2025 |
| NCT05507931 | Recruiting | N/A | Broccoli Sprouts for Mild Ulcerative Colitis | May 23, 2023 | September 2025 |
| NCT05535946 | Recruiting | Phase 3 | ABTECT - Maintenance | January 16, 2023 | June 2025 |
| NCT05542459 | Recruiting | Multi-omics to Predict Responses to Biologics in IBD | January 1, 2020 | November 1, 2024 | |
| NCT05561738 | Recruiting | N/A | Nicotinamide Riboside in Ulcerative Colitis | February 28, 2024 | December 31, 2025 |
| NCT05570006 | Recruiting | Phase 2 | Study of ABBV-668 Oral Capsules to Assess Adverse Events and Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis | March 16, 2023 | May 30, 2026 |
| NCT05578313 | Recruiting | Inflammatory Bowel Diseases (IBD) Cannabis Registry | July 10, 2019 | July 10, 2024 | |
| NCT05587673 | Recruiting | Phase 1 | High Dose Steroid Therapy to Treat Flares in Patients With Inflammatory Bowel Disease (IBD) | October 6, 2022 | December 2026 |
| NCT05598489 | Recruiting | Development of Novel Fecal Microbial Biomarkers for Inflammatory Bowel Disease | December 7, 2022 | July 31, 2024 | |
| NCT05598684 | Recruiting | SAPHIR : Assessment of Predictive Factors for Persistence of Treatment After Initiation of Adalimumab With a Biosimilar (Adalimumab Fresenius KaBI or Substitution of Reference Adalimumab With the Fresenius Kabi Adalimumab Biosimilar in Patients With Chronic Inflammatory Diseases | November 24, 2022 | December 30, 2025 | |
| NCT05615779 | Recruiting | N/A | Personalized B-fructan Diet in Inflammatory Bowel Disease Patients | August 1, 2023 | September 1, 2025 |
| NCT05626088 | Recruiting | A Study in Adults With Inflammatory Bowel Disease (IBD) Receiving Vedolizumab in the Patient Support Program (PSP) in Brazil | April 10, 2023 | January 2, 2025 | |
| NCT05626166 | Recruiting | Phase 3 | the Efficacy and Safety of Diosmin in Patients With Ulcerative Colitis | December 15, 2022 | November 2024 |
| NCT05628701 | Recruiting | N/A | Colectomy Reconstruction for Ulcerative Colitis, Ileorectal Anastomosis vs Ileal Pouch-Anal Anastomosis in Ulcerative Colitis. | April 4, 2017 | December 31, 2029 |
| NCT05633706 | Recruiting | Evaluation of the SIMBA Capsule for Small Intestinal Dysbiosis | January 9, 2023 | January 1, 2025 | |
| NCT05635266 | Recruiting | Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives | October 26, 2021 | October 2025 | |
| NCT05636709 | Recruiting | National GMA Post-market Clinical Follow-up Study (GRACE) | January 11, 2022 | December 31, 2025 | |
| NCT05644665 | Recruiting | Phase 3 | A Study to Evaluate Efficacy and Long-term Safety of Oral Ozanimod in Chinese Participants With Moderately to Severely Active Ulcerative Colitis (UC) | December 9, 2022 | April 14, 2027 |
| NCT05651542 | Recruiting | N/A | A Comprehensive Self-Management Intervention for Individuals With Inflammatory Bowel Disease | March 14, 2023 | March 31, 2025 |
| NCT05652621 | Recruiting | N/A | Efficacy of Probiotics in Patients With IBD | July 31, 2022 | December 31, 2026 |
| NCT05653011 | Recruiting | Predictors of Prognosis in IBD Patients | March 11, 2013 | December 31, 2024 | |
| NCT05662059 | Recruiting | N/A | Respiratory-gated Auricular Vagal Afferent Nerve Stimulation (RAVANS) Study in Ulcerative Colitis | January 12, 2023 | December 30, 2023 |
| NCT05666960 | Recruiting | Phase 1 | R-3750 in Patients With Mild to Moderate Ulcerative Colitis | February 27, 2023 | February 2025 |
| NCT05672199 | Recruiting | Phase 2 | Long-term Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis | April 28, 2023 | May 31, 2028 |
| NCT05673278 | Recruiting | Non-Invasive Monitoring Through Bowel Ultrasound in Paediatric Inflammatory Bowel Disease Study | May 1, 2023 | May 1, 2024 | |
| NCT05679622 | Recruiting | N/A | Fecal Microbiota Transplantation in Pediatric Ulcerative Colitis (UC) | December 1, 2022 | June 30, 2025 |
| NCT05686135 | Recruiting | N/A | 90Second IBD for the Improvement of Self Efficacy and Quality of Life in Inflammatory Bowel Disease Patients | June 7, 2023 | July 2024 |
| NCT05702879 | Recruiting | Combined Microbiota and Metabolic Signature in Ulcerative Colitis Predicts Anti-Inflammatory Therapy Success | September 6, 2023 | January 31, 2025 | |
| NCT05704413 | Recruiting | Digestive Biobank for Exploring Microbiota-host Interactions | June 17, 2021 | September 17, 2026 | |
| NCT05722236 | Recruiting | N/A | IBD Strong Peer2Peer for Self-Management of Psychological Distress | June 1, 2023 | March 2025 |
| NCT05733845 | Recruiting | N/A | Evaluation of Molecular Mechanisms of Non-response to Therapy in Patients With Inflammatory Bowel Disease | June 14, 2023 | August 1, 2030 |
| NCT05739162 | Recruiting | N/A | A Study of Endoscopic Sleeve Gastroplasty for Obesity in Ulcerative Colitis | September 20, 2023 | January 2025 |
| NCT05743010 | Recruiting | Phase 1 | A Phase 1b Study to Evaluate APL-1401 in Patients With Moderately to Severely Active Ulcerative Colitis | January 26, 2023 | April 2025 |
| NCT05743374 | Recruiting | N/A | Micronutrient and Additive Modifications May Optimize Diet To Health | April 2, 2024 | February 2026 |
| NCT05767021 | Recruiting | Phase 3 | A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis | May 17, 2023 | March 31, 2025 |
| NCT05780723 | Recruiting | N/A | Treatment of Ulcerative Colitis With Rectal Instillation of Qinghua Quyu Prescription(QHQYP) | April 4, 2023 | December 31, 2025 |
| NCT05782907 | Recruiting | Phase 3 | Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis. | November 6, 2023 | October 31, 2033 |
| NCT05784246 | Recruiting | Phase 3 | A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely or Active Ulcerative Colitis | November 22, 2023 | March 31, 2027 |
| NCT05785715 | Recruiting | Phase 2 | Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis | April 24, 2023 | December 31, 2025 |
| NCT05791487 | Recruiting | N/A | Combination of Diet and Oral Budesonide for Ulcerative Colitis | December 1, 2023 | September 1, 2026 |
| NCT05791526 | Recruiting | An Observational Study to Assess Change in Disease Activity and Adverse Events of Rinvoq in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Japan | December 19, 2022 | November 30, 2025 | |
| NCT05817942 | Recruiting | Prospective Observational Study of Effectiveness and Safety of Filgotinib in Participants With Ulcerative Colitis (UC) | June 12, 2023 | December 2025 | |
| NCT05852574 | Recruiting | Phase 1 | CP101 for the Treatment of Ulcerative Colitis | September 1, 2023 | June 2, 2025 |
| NCT05876494 | Recruiting | Serum Lactate and Ulcerative Colitis | June 1, 2023 | December 31, 2023 | |
| NCT05886322 | Recruiting | Remote Monitoring of IBD | June 7, 2022 | June 2024 | |
| NCT05895981 | Recruiting | N/A | Exploratory Clinical Trial of Safety and Efficacy of Sacral Nerve Stimulation in Patients With Ulcerative Colitis. | July 20, 2023 | March 1, 2025 |
| NCT05913817 | Recruiting | The Evaluation of Injection Site Pain and Adherence in Patients Switching From a Low To High Concentration Adalimumab (AVT-02) Across Multiple Indications. | January 9, 2023 | November 13, 2024 | |
| NCT05916274 | Recruiting | N/A | Exploration of the Activity of DNA Located Outside of Cellular Nucleus to Amplify Inflammation in Inflammatory Bowel Disease in Children Through Biological Pathway Cyclic GMP-AMP Synthase (cGAS) - Stimulator of Interferon Genes (STING) | May 31, 2023 | June 2026 |
| NCT05975047 | Recruiting | Phase 1 | A Study of LIV001 in Healthy Subjects and Those With Mild-to-Moderate Active Ulcerative Colitis (UC) | October 24, 2023 | July 30, 2024 |
| NCT05987852 | Recruiting | N/A | Hyperbaric Oxygen Therapy for Ulcerative Colitis | January 9, 2024 | September 1, 2027 |
| NCT05998213 | Recruiting | Phase 2 | Transfer of Feces in Ulcerative Colitis 2 | December 5, 2018 | December 1, 2025 |
| NCT05998577 | Recruiting | N/A | A Personalized Approach to Abdominal Pain in Irritable Bowel Syndrome | May 19, 2023 | May 19, 2025 |
| NCT06026449 | Recruiting | N/A | Gluten-free Diet in PSC and IBD | January 1, 2023 | August 30, 2026 |
| NCT06029972 | Recruiting | Phase 2 | Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis | December 5, 2023 | June 2026 |
| NCT06030882 | Recruiting | N/A | Improving Patient Outcomes Through the Implementation of an IBD Biologic Care Pathway | March 25, 2024 | March 2025 |
| NCT06042387 | Recruiting | Diverse Ancestry Study in IBD | May 1, 2022 | September 2027 | |
| NCT06050811 | Recruiting | N/A | Prebiotics in Reducing Inflammation and Clinical Endpoints in Ulcerative Colitis (PRInCE-UC) | January 3, 2024 | November 2024 |
| NCT06052059 | Recruiting | Phase 3 | A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001) | October 25, 2023 | December 17, 2029 |
| NCT06071312 | Recruiting | Phase 1/Phase 2 | FMT in Patients With Recurrent CDI and Ulcerative Colitis: Single Infusion Versus Sequential Approach | September 23, 2023 | September 24, 2025 |
| NCT06073873 | Recruiting | A Post-Marketing Surveillance Study to Assess Safety of Ozanimod in Patients With Moderate to Severe Active UC in Korea | May 30, 2024 | April 1, 2028 | |
| NCT06080048 | Recruiting | Phase 1 | A Clinical Trial to Assess the Safety of SOR102 in Healthy Participants and Patients With Ulcerative Colitis | October 24, 2023 | April 2025 |
| NCT06094608 | Recruiting | N/A | IBD-Sleep: A Pilot Study Looking at Changes in Sleep Timing and IBD Symptoms | February 1, 2024 | May 31, 2026 |
| NCT06107179 | Recruiting | Monitoring of Pediatric Inflammatory Bowel Diseases Using Multispectral Optoacoustic Tomography | January 24, 2024 | February 1, 2026 | |
| NCT06109441 | Recruiting | Phase 2 | Efficacy/Safety of ALTB-268 in Subjects w/Moderately to Severely Active UC Refractory to Biologics | December 4, 2023 | March 2026 |
| NCT06116331 | Recruiting | The Mind-Body IBD Study: Understanding the Mind-body Connection in IBD | April 1, 2023 | December 31, 2024 | |
| NCT06117423 | Recruiting | Phase 1/Phase 2 | Fluorescence Imaging of Adalimumab-680LT in Inflammatory Bowel Disease | March 2024 | June 2025 |
| NCT06127043 | Recruiting | Phase 2 | A Study of Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Ulcerative Colitis (ROSETTA) | December 4, 2023 | May 2026 |
| NCT06137183 | Recruiting | Phase 2 | A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants With Moderate to Severe Ulcerative Colitis (UC) | May 1, 2024 | May 1, 2027 |
| NCT06206811 | Recruiting | Phase 1 | Phase 1 Study to Investigate OD-07656 in Healthy Adult Participants | February 12, 2024 | October 2025 |
| NCT06231264 | Recruiting | N/A | Transcutaneous Electrical Acustimulation in the Treatment of Mild to Moderate Ulcerative Colitis | January 19, 2024 | March 1, 2025 |
| NCT06254950 | Recruiting | Phase 2 | A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis | March 29, 2024 | August 4, 2027 |
| NCT06257875 | Recruiting | Phase 2 | A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis | March 23, 2024 | April 23, 2027 |
| NCT06260267 | Recruiting | Phase 1 | A Phase 1b Proof-of-concept Trial Exploring the Effects of FE 999322 and FE 999324 in Adults With Mild to Moderate Ulcerative Colitis | March 12, 2024 | January 15, 2026 |
| NCT06269185 | Recruiting | Comparison Between Infliximab and Adalimumab on Patients With Ulcerative Colitis | March 6, 2024 | March 1, 2025 | |
| NCT06290934 | Recruiting | Phase 2 | Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis | March 27, 2024 | March 2028 |
| NCT06311123 | Recruiting | Understanding Ozanimod's MOA Via Mass Cytometry in Ulcerative Colitis | October 6, 2023 | September 30, 2026 | |
| NCT06351696 | Recruiting | N/A | The Effects of Bromelain Supplement in Patients With Ulcerative Colitis | April 20, 2024 | August 10, 2024 |
| NCT06363383 | Recruiting | Phase 1 | A Phase 1 Study to Evaluate the Safety of an Oral Biologic in Healthy Participants | May 9, 2024 | May 2025 |
| NCT06392061 | Recruiting | N/A | Effect of Probiotic Administration on Patients With Inflammatory Bowel Disease | April 1, 2024 | June 30, 2024 |
| NCT06398808 | Recruiting | Phase 2 | A Study to Evaluate the Efficacy and Safety of ZYIL1 Oral Capsules for the Treatment of Patients With Mild to Moderately Active Ulcerative Colitis Resistant or Intolerant to Oral Aminosalicylates | April 8, 2024 | October 30, 2024 |
| NCT06407674 | Recruiting | Non-invasive Assessment of RECTUM (POUCH) by US (RECT-US) in a Cohort of IBD Patients | January 10, 2024 | May 28, 2025 | |
| NCT06421818 | Recruiting | Phase 2 | Effect and Mechanism of Baitouweng Decoction for Large Intestine Damp-heat Syndrome of Ulcerative Colitis | May 2024 | December 30, 2026 |
| NCT04143490 | Suspended | N/A | Effects of Exercise in Patients With Ulcerative Colitis | November 4, 2019 | December 2025 |
| NCT04225819 | Suspended | N/A | Adjunctive Treatment With Vitamin D3 in Patients With Active IBD | October 1, 2020 | April 1, 2027 |
| NCT04985981 | Suspended | The Prediction of Anastomotic Insufficiency Risk After Colorectal Surgery (PANIC) Study | April 1, 2021 | December 31, 2022 | |
| NCT05252273 | Suspended | Assessment of Patients With Acute Pouchitis Treated With Antibiotics | December 7, 2021 | December 9, 2024 | |
| NCT02361957 | Suspended | N/A | The Effect of the Multispecies Probiotic Ecologic 825 Versus Placebo in Ulcerative Colitis Patients | November 2014 | December 2015 |
| NCT04456400 | Suspended | Enhancing Ultrasound & Photoacoustic for Recognition of Intestinal Abnormalities | February 3, 2021 | April 2024 | |
| NCT04898530 | Suspended | Diet Patterns in IBD in Central Texas | June 8, 2021 | December 31, 2024 | |
| NCT03358706 | Suspended | Phase 1 | A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis | February 2, 2018 | October 1, 2024 |
| NCT04995783 | Terminated | Predicting Medication Response for Autoimmune Disease | September 1, 2020 | August 1, 2022 | |
| NCT03616821 | Terminated | Phase 2 | Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis | August 7, 2018 | October 23, 2023 |
| NCT01061996 | Terminated | Phase 2 | Basiliximab Maintenance in Ulcerative Colitis | July 2007 | December 2008 |
| NCT03604536 | Terminated | Individualization Treatment Through a Self-managed Web-based Solution in Ulcerative Colitis | December 2, 2019 | December 31, 2021 | |
| NCT03597971 | Terminated | Phase 1 | HMPL004-6599 Phase I Dose-escalating Study | March 20, 2018 | November 19, 2018 |
| NCT03798405 | Terminated | N/A | Reactive vs. Proactive Pain Control in IBD | January 1, 2019 | July 1, 2022 |
| NCT02864264 | Terminated | Phase 1 | Single Ascending Dose and Multiple Ascending Dose Study in Healthy Participants and Proof of Mechanism Study in Patients With Ulcerative Colitis | September 14, 2016 | September 27, 2017 |
| NCT03800420 | Terminated | Phase 2 | Efficacy and Safety of BBT-401-1S in Ulcerative Colitis | April 22, 2019 | July 31, 2020 |
| NCT03802214 | Terminated | Ulcerative Colitis - Vedolizumab- With/Without Prior Exposure to Anti-TNF（Tumor Necrosis Factor）Therapy | October 29, 2020 | December 11, 2020 | |
| NCT02413047 | Terminated | N/A | Evaluate if Response to Infliximab or Adalimumab May be Regained With an Immunomodulator | May 2015 | February 2018 |
| NCT00968721 | Terminated | Decisional Influences and Inflammatory Bowel Disease (IBD) Patients' Medication Use | June 2010 | December 2011 | |
| NCT00152841 | Terminated | Phase 2 | Effect of Iron and Vitamin E Supplementation on Disease Activity in Patients With Either Crohn's Disease or Ulcerative Colitis | June 2002 | |
| NCT02142725 | Terminated | Phase 3 | Phosphatidylcholine (LT-02) for Induction of Remission in Ulcerative Colitis | July 21, 2014 | December 16, 2016 |
| NCT03587519 | Terminated | N/A | Short Versus Long Interval to Ileostomy Reversal After Ileal Pouch Surgery | November 6, 2018 | March 31, 2021 |
| NCT00790478 | Terminated | Phase 2 | Melatonin and Ulcerative Colitis: A Pilot Clinical Trial | January 2009 | April 2010 |
| NCT01567956 | Terminated | Phase 3 | Propionyl-L-Carnitine Hydrochloride in Patients With Mild Ulcerative Colitis; Efficacy, Safety and Tolerability Study | April 2012 | January 2014 |
| NCT02520284 | Terminated | Phase 2/Phase 3 | Safety and Efficacy of Andecaliximab (GS-5745) in Adults With Moderately to Severely Active Ulcerative Colitis | September 2015 | November 2016 |
| NCT02128503 | Terminated | N/A | Prevalence and Clinical Course of Chronic Hep B Infection in IBD and Rheumatologic Disease | February 2013 | October 16, 2015 |
| NCT02326155 | Terminated | To Evaluate the Safety and Efficacy of Remsima™ in Patients With Crohn's Disease (CD) or Ulcerative Colitis (UC) | December 8, 2014 | February 28, 2020 | |
| NCT00279435 | Terminated | Phase 2/Phase 3 | Study of Visilizumab Versus Placebo in Subjects With Intravenous Steroid-refractory Ulcerative Colitis Previously Responsive in a Visilizumab Study | August 2006 | August 2007 |
| NCT03521232 | Terminated | Phase 1/Phase 2 | A Study of Niclosamide Enemas in Subjects With Active Ulcerative Proctitis or Ulcerative Proctosigmoiditis | May 15, 2018 | October 4, 2022 |
| NCT02118584 | Terminated | Phase 3 | Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies | September 15, 2014 | October 5, 2023 |
| NCT03478956 | Terminated | Phase 1 | A Phase I Study Of Etrolizumab Followed By Open-Label Extension And Safety Monitoring In Pediatric Patients With Moderate To Severe Ulcerative Colitis Or Moderate To Severe Crohn's Disease | March 27, 2018 | September 27, 2023 |
| NCT04881370 | Terminated | Quality of Life for Patients With Chronic Paediatric Onset Inflammatory Bowel Disease (IBD) | October 9, 2020 | June 28, 2021 | |
| NCT02488954 | Terminated | N/A | Interest of Propionibacterium Freudenreichii for the Treatment of Mild to Moderate Ulcerative Colitis | February 12, 2016 | June 30, 2017 |
| NCT00586807 | Terminated | N/A | Metabolic Response to Infliximab in Pediatric Ulcerative Colitis | June 2005 | September 2008 |
| NCT01742754 | Terminated | N/A | Fecal Microbiota Transplantation for Ulcerative Colitis | October 2012 | May 2013 |
| NCT02058524 | Terminated | Phase 1 | A Pilot and Feasibility Study of Fecal Microbiota Transplantation for Ulcerative Colitis | June 2013 | June 2016 |
| NCT03455751 | Terminated | N/A | Precision Pain Management for Major Abdominal Surgery in Colorectal Surgery | April 17, 2018 | January 9, 2019 |
| NCT02878083 | Terminated | N/A | Development of a Biomarker of Efficacy of Vedolizumab (EnTyvio®) in Patients With ulcErative ColiTis (DETECT) | January 11, 2017 | January 1, 2021 |
| NCT03908073 | Terminated | N/A | Electrical Vagal Nerve Stimulation in Ulcerative Colitis | October 30, 2018 | March 15, 2021 |
| NCT03415711 | Terminated | N/A | PRObiotic VSL#3® for Maintenance of Clinical and Endoscopic REMission in Ulcerative Colitis | April 28, 2017 | April 24, 2019 |
| NCT04277546 | Terminated | Phase 2 | Open-label Extension Study of Brazikumab in Ulcerative Colitis | March 3, 2020 | October 10, 2023 |
| NCT02895100 | Terminated | Phase 2 | Safety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative Colitis | December 2016 | March 26, 2018 |
| NCT01960426 | Terminated | Phase 4 | Evaluation of Health Costs and Resource Utilization | April 2014 | May 2015 |
| NCT00360022 | Terminated | N/A | Transition of Inflammatory Bowel Disease (IBD) Patients From Pediatric to Adult Gastroenterologist (GI) | August 2006 | February 2011 |
| NCT03943550 | Terminated | Phase 1 | Double-Blinded, Placebo-Controlled Phase 1b Study for Safety, PK, Efficacy, PD of RO7049665 in Participants With Ulcerative Colitis (UC) | May 13, 2019 | July 22, 2021 |
| NCT04478825 | Terminated | Phase 1 | Efficacy and Safety of Rectally Administered BBT-401-1S in Subjects With Ulcerative Colitis | June 1, 2021 | August 24, 2021 |
| NCT02481687 | Terminated | The Value of I-Scan and Confocal Laser Endomicroscopy for the Assessment of Chronic Inflammatory Bowel Disease | June 2015 | June 2017 | |
| NCT01882764 | Terminated | Phase 3 | HMPL-004 Maintenance Treatment in Subjects With Mild to Moderate Ulcerative Colitis | June 2013 | October 2014 |
| NCT00355901 | Terminated | An Observational Follow-up Study for Subjects Receiving Salvage Therapy After Previous Treatment in a Visilizumab Study for Intravenous Steroid-Refractory Ulcerative Colitis | September 2006 | November 2012 | |
| NCT01716039 | Terminated | Phase 2 | Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With Ulcerative Colitis (UC) | June 2013 | July 18, 2016 |
| NCT03341962 | Terminated | Phase 2 | Phase 2 Dose-finding IMU-838 for Ulcerative Colitis | March 15, 2018 | November 16, 2022 |
| NCT01882426 | Terminated | Phase 4 | Care Path for the Management of Ulcerative Colitis | May 2014 | May 2016 |
| NCT05579444 | Terminated | Systems Biology of Gastrointestinal and Related Diseases | November 11, 2022 | November 29, 2023 | |
| NCT02954159 | Terminated | Phase 3 | Vedolizumab Monotherapy Vs Combination Therapy With Tacrolimus in UC | May 18, 2017 | January 31, 2019 |
| NCT00279422 | Terminated | Phase 2/Phase 3 | A Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis | February 2006 | August 2007 |
| NCT03977480 | Terminated | Phase 2 | Phase II Study of Hemay007 in Patients With Active Ulcerative Colitis | August 13, 2019 | August 12, 2022 |
| NCT03980405 | Terminated | N/A | Combination of Diet and 5ASA ( 5-aminosalicylic Acid) for Ulcerative Colitis | April 1, 2020 | May 30, 2022 |
| NCT03986996 | Terminated | Phase 2 | Antimicrobial Therapy for Ulcerative Colitis (UC) | July 25, 2019 | May 30, 2022 |
| NCT01375179 | Terminated | Phase 2 | Efficacy & Safety in Moderately Active Refractory Ulcerative Colitis Patients | December 2010 | May 2012 |
| NCT00254618 | Terminated | Phase 1 | A Study of Asacol Absorption, Metabolism and Excretion in Children and Adolescents With Ulcerative Colitis. | October 2005 | June 2008 |
| NCT03298022 | Terminated | Phase 2 | Efficacy&Safety of ALTB-168 in Patients With Moderate to Severe Active,Anti-TNF Alpha and/or Anti-integrin Refractory UC | May 4, 2018 | June 1, 2020 |
| NCT00268164 | Terminated | Phase 2 | Lactobacillus Acidophilus and Bifidobacterium Animalis Subsp. Lactis, Maintenance Treatment in Ulcerative Colitis | June 2004 | March 2007 |
| NCT04434872 | Terminated | Phase 2 | Fecal Microbiota Transplantation as a Treatment for Ulcerative Colitis | July 2015 | July 2016 |
| NCT03281304 | Terminated | Phase 4 | A Study of Tofacitinib in Patients With Ulcerative Colitis in Stable Remission | November 16, 2017 | March 18, 2022 |
| NCT01004185 | Terminated | Phase 3 | Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis | October 2009 | March 2011 |
| NCT01861249 | Terminated | Phase 2 | Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC) | July 2013 | April 2016 |
| NCT03269695 | Terminated | Phase 2 | Efficacy, Safety and Tolerability of PF-06687234 as Add-on Therapy to Infliximab in Active UC Subjects Not in Remission. | December 20, 2017 | January 7, 2021 |
| NCT00457171 | Terminated | Phase 1 | GI-270384 Study In Patients With Mild To Moderate Ulcerative Colitis | December 2004 | |
| NCT01659138 | Terminated | Phase 2 | Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis | August 2012 | April 2016 |
| NCT00349388 | Terminated | N/A | Safety and Compliance of Taking Mesalamine Once a Day in Pediatric Patients | July 2006 | January 2011 |
| NCT04032652 | Terminated | Phase 2 | Use of Rectal Dialysis Technique to Measure Rectal 5-ASA Levels in Healthy Volunteers Receiving Asacol | December 2012 | December 5, 2014 |
| NCT03259334 | Terminated | Phase 3 | Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis | February 9, 2018 | October 23, 2020 |
| NCT00751933 | Terminated | Phase 2 | Vaccines and Dietary Oats in the Treatment of Ulcerative Colitis | October 2008 | June 2010 |
| NCT01538251 | Terminated | Phase 3 | Efficacy, Safety and Tolerability of Propionyl-L-Carnitine Hydrochloride in Patients With Mild Ulcerative Colitis | April 2012 | December 2013 |
| NCT01706159 | Terminated | Phase 2 | A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis | October 2012 | July 2013 |
| NCT03259308 | Terminated | Phase 3 | Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis | December 5, 2017 | October 6, 2020 |
| NCT02734589 | Terminated | N/A | Fecal Transplantation Using a Diet for Donor and Recipient in Refractory Colitis | January 24, 2017 | December 30, 2020 |
| NCT00979485 | Terminated | Microparticles in Pediatric Inflammatory Disease | August 2009 | May 2011 | |
| NCT04100291 | Terminated | N/A | Faecal Microbiota Transplantation in the Treatment of Chronic Pouchitis | July 1, 2019 | March 1, 2022 |
| NCT00537316 | Terminated | Phase 3 | Efficacy & Safety of Infliximab Monotherapy Vs Combination Therapy Vs AZA Monotherapy in Ulcerative Colitis (Part 1) Maintenance Vs Intermittent Therapy for Maintaining Remission (Part 2)(Study P04807) | July 2007 | February 2010 |
| NCT04130919 | Terminated | Phase 2 | Study to Evaluate the Efficacy and Safety of Tilpisertib in Adults With Moderately to Severely Active Ulcerative Colitis | December 20, 2019 | December 14, 2021 |
| NCT04131322 | Terminated | Phase 4 | Loss of Response of Adalimumab Biosimilar vs Adalimumab Original, in Inflammatory Bowel Disease. | October 10, 2019 | June 8, 2020 |
| NCT03169894 | Terminated | Phase 1 | Evaluation of the Safety, Tolerability, and Efficacy of MDGN-002 in Adults With Moderate to Severe Active Crohn's Disease or Ulcerative Colitis | July 14, 2017 | October 12, 2021 |
| NCT00805285 | Terminated | Phase 2 | The Use of Oral Budesonide and Rectal Hydrocortisone for the Treatment of Active Ulcerative Colitis | October 2008 | March 2010 |
| NCT00209287 | Terminated | Phase 4 | Study of Effects and of Modifications in Apoptosis Regulators Observed After Stopping 5-ASA Treatment in Patients With Inactive Ulcerative Colitis | June 2005 | September 2007 |
| NCT02808390 | Terminated | Phase 2 | Efficacy and Safety Study of GED-0507-34-Levo for Treatment of UC | November 28, 2016 | July 31, 2017 |
| NCT03209232 | Terminated | N/A | Infliximab Accelerated Induction in Moderate to Severe Pediatric UC | April 16, 2018 | September 1, 2021 |
| NCT00307827 | Terminated | Phase 2 | Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis (IVSR-UC) | April 2006 | November 2007 |
| NCT04159311 | Terminated | N/A | Osteopathy on IBS Symptoms in Patients With Ulcerative Colitis in Remission | November 18, 2019 | November 2, 2021 |
| NCT00061282 | Terminated | Phase 1/Phase 2 | Clotrimazole Enemas for Pouchitis in Children and Adults | September 30, 2002 | December 1, 2020 |
| NCT04576000 | Terminated | Identification of Biomarkers of Janus Kinase Inhibitor Therapy in Patients With Ulcerative Colitis | August 25, 2020 | December 2, 2021 | |
| NCT00553163 | Terminated | N/A | Hypnotherapy for Prevention of Relapse in Ulcerative Colitis: a Randomised, Single-blind, Controlled Clinical Trial | October 2007 | April 2010 |
| NCT03218202 | Terminated | Stricture Definition and Treatment (STRIDENT) Observational Study. | October 9, 2017 | August 29, 2019 | |
| NCT00702611 | Terminated | Phase 4 | Efficacy Study of Granulocytapheresis Plus Steroids vs Steroids Alone in Active Steroid Dependant Ulcerative Colitis | June 2008 | July 2013 |
| NCT01002287 | Terminated | N/A | An Evaluation of SprayShield in Reducing Post-Operative Adhesion Formation Following Major Open Abdominal Surgery | October 2009 | May 2011 |
| NCT00947674 | Terminated | Phase 4 | A Study of Leukocytapheresis (LCAP) in Patients With Ulcerative Colitis (UC) | May 2009 | October 2012 |
| NCT00296556 | Terminated | Phase 2 | Therapeutic Study of ONO-4819CD for Ulcerative Colitis | February 2006 | March 2008 |
| NCT01805791 | Terminated | Phase 3 | A Phase III Trial of HMPL-004 in Patients With Mild to Moderate Active Ulcerative Colitis | March 2013 | October 2014 |
| NCT00837304 | Terminated | Colon Capsule Endoscopy Versus Standard Colonoscopy in Ulcerative Colitis | January 2009 | July 2012 | |
| NCT00663819 | Terminated | N/A | Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses | April 2008 | October 2012 |
| NCT02266849 | Terminated | Phase 3 | Loperamide vs. Placebo's Effect on Ileostomy Output: A Clinical Randomized Blinded Cross-over Study | October 2014 | August 2015 |
| NCT01678911 | Terminated | Phase 4 | Efficacy of Gralise® for Chronic Pelvic Pain | August 2012 | June 2014 |
| NCT02579733 | Terminated | Phase 4 | Azathioprine Based on Endoscopy After Clinical Remission in Moderate to Severe Ulcerative Colitis | February 1, 2016 | December 1, 2018 |
| NCT01164904 | Terminated | Phase 1 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis | July 2010 | March 2013 |
| NCT00038922 | Terminated | Phase 1 | Study Evaluating rhIL-11 in Left-Sided Ulcerative Colitis | ||
| NCT02849951 | Terminated | Phase 3 | A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC) | July 2016 | August 2019 |
| NCT00659867 | Terminated | N/A | Endomicroscopy in Ulcerative Colitis | December 2008 | September 2016 |
| NCT04626947 | Terminated | Phase 4 | Prevention of Recurrent Clostridium Difficile Infection (CDI) in Patients With Inflammatory Bowel Disease (IBD). | October 30, 2021 | May 31, 2024 |
| NCT04968951 | Terminated | Early Phase 1 | Refined Fecal Microbiota Transplantation (FMT) for Ulcerative Colitis (UC) | November 10, 2021 | August 22, 2022 |
| NCT02182466 | Terminated | German Colon Capsule Registry | June 2014 | March 30, 2017 | |
| NCT04985968 | Terminated | Phase 3 | The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis | November 24, 2021 | December 20, 2023 |
| NCT00621257 | Terminated | N/A | Vitamin D Levels in Children With IBD | January 2008 | March 2011 |
| NCT05474742 | Terminated | N/A | The Nori Health App | April 25, 2022 | September 1, 2022 |
| NCT03724929 | Terminated | N/A | Value of Pharmacokinetic Assays in the Prediction of Therapeutic Response in Ulcerative Colitis | March 4, 2019 | June 28, 2022 |
| NCT05479058 | Terminated | Phase 3 | A Study Evaluating the Effect of Filgotinib Dose De-escalation in Participants With Ulcerative Colitis (UC) in Remission | July 26, 2022 | October 9, 2023 |
| NCT04556383 | Terminated | Phase 2 | A Study With GB004 in Adult Subjects With Active Ulcerative Colitis (UC) | October 19, 2020 | June 1, 2022 |
| NCT03656627 | Terminated | Phase 1 | Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease | June 27, 2019 | March 18, 2021 |
| NCT03759041 | Terminated | Phase 2 | A Study to Assess Efficacy and Safety of SER-287 in Adults With Active Mild-to-Moderate Ulcerative Colitis | December 19, 2018 | October 13, 2021 |
| NCT03650413 | Terminated | Phase 2 | An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease | January 14, 2019 | July 12, 2022 |
| NCT02144350 | Terminated | Phase 2/Phase 3 | Hyperbaric Oxygen for Ulcerative Colitis | August 2013 | November 2016 |
| NCT03768219 | Terminated | Phase 1 | Study to Evaluate APVO210 in Healthy Subjects, Patients With Psoriasis, and Patients With Ulcerative Colitis | March 18, 2019 | June 30, 2020 |
| NCT03772145 | Terminated | Tofacitinib Response in Ulcerative Colitis - a Real World Prospective Multi-center Study | November 27, 2018 | January 29, 2024 | |
| NCT02998112 | Unknown status | Phase 4 | Fecal Microbiota Transplantation for Ulcerative Colitis Through Colonic Transendoscopic Enteral Tubing | December 2016 | December 2017 |
| NCT04695184 | Unknown status | N/A | Subjective Near-infrared Fluorescence Guidance in Perfusion Assessment of Ileal Pouch Formation and Ileal-pouch-anal Anastomosis | February 1, 2019 | January 2021 |
| NCT04695964 | Unknown status | N/A | Objective Perfusion Rate Assessment by Near-infrared Fluorescence in Ileal Pouch Formation and Ileal-pouch-anal Anastomosis | February 1, 2019 | January 2021 |
| NCT02610569 | Unknown status | N/A | Comparison of PillCamCOLON (C2) Capsule and Standard Endoscopy for the Evaluation of Patients With Ulcerative Colitis | April 2014 | September 2017 |
| NCT04709445 | Unknown status | N/A | Perfusion Rate Assessment by Near-infrared Fluorescence in Gastrointestinal Anastomoses | March 1, 2020 | December 2021 |
| NCT00805428 | Unknown status | Importance of CD4+CD25+ly in UC1. Investigation of Difference Between Blood Concentration IL 17, IL 33, Regulatory T ly in Patients With UC and Control Group | September 2008 | ||
| NCT04749576 | Unknown status | N/A | Saffron as Anti Inflammatory Agent In Patients With Inflammatory Bowel Disease | December 15, 2020 | December 10, 2023 |
| NCT04750135 | Unknown status | Phase 2 | Assessment of Metformin as Adjuvant Therapy in Patients With Ulcerative Colitis | February 7, 2021 | June 1, 2021 |
| NCT01586533 | Unknown status | Phase 2 | Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis | June 2012 | |
| NCT02575040 | Unknown status | Phase 3 | Efficacy of Fecal Microbiota Transplantation for Inflammatory Bowel Disease | May 2015 | May 2020 |
| NCT04818788 | Unknown status | Hematological Indices and Fecal Calprotectin Predict Histological Remission in Ulcerative Colitis | April 1, 2021 | June 1, 2022 | |
| NCT02476643 | Unknown status | Integrative Gastroenterology - an Observational Trial | October 2015 | December 2018 | |
| NCT02442037 | Unknown status | Phase 1/Phase 2 | Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Active Ulcerative Colitis | May 2015 | December 2017 |
| NCT02435160 | Unknown status | Phase 2/Phase 3 | The Study of Efficacy and Mechanism in Fecal Microbiota Transplantation in the Treatment of Ulcerative Colitis | May 2015 | |
| NCT02383953 | Unknown status | SSAT 054: Non Genetic Factors in the Pathogenesis of IBD in Twins | May 2015 | October 2017 | |
| NCT02335281 | Unknown status | Phase 2 | Standardized Fecal Microbiota Transplantation for Inflammatory Bowel Disease | January 2015 | December 2017 |
| NCT04882007 | Unknown status | Phase 2 | Study of OSE-127 vs Placebo in Patients With Moderate to Severe Active Ulcerative Colitis | October 2, 2020 | March 2023 |
| NCT04882566 | Unknown status | Assessment of Nutritional Knowledge in Patients With Inflammatory Bowel Disease | August 2021 | April 2022 | |
| NCT04882683 | Unknown status | N/A | Clinical Study of Cord Blood Mononuclear Cells on Treatment of Hormone-resistant or Hormone-dependent Ulcerative Colitis | June 1, 2021 | December 31, 2022 |
| NCT04887428 | Unknown status | Occupational Insertion and Educational Level of Adult Patients With Pediatric Early Inflammatory Bowel Disease (IBD) | November 28, 2019 | October 2021 | |
| NCT02277470 | Unknown status | Study of the Pharmacokinetics of Golimumab in Moderate to Severe Ulcerative Colitis | August 2014 | August 2016 | |
| NCT00398593 | Unknown status | Phase 3 | Methods of Improvement Adherence With Therapy in Ulcerative Colitis. | December 2007 | April 2009 |
| NCT02264275 | Unknown status | N/A | Influence of Aerobic Exercise Training (AET) on Inflammatory Bowel Disease (IBD) in Children and Adolescents | October 2014 | March 2015 |
| NCT02186886 | Unknown status | Phase 4 | Physiological Intermolecular Modification Spectroscopy (PIMS) in Ulcerative Colitis With Golimumab | June 2014 | December 2015 |
| NCT00793130 | Unknown status | N/A | The Efficacy and Tolerability of Coltect as Add-on in Patients With Active Ulcerative Colitis - an Open Label | November 2008 | November 2009 |
| NCT01505842 | Unknown status | N/A | Chromoendoscopy for Dysplasia Detection in Chronic Inflammatory Bowel Disease | February 2011 | April 4, 2019 |
| NCT05030064 | Unknown status | N/A | Clinical Study on the Fecal Microbiota Transplantation in the Treatment of Ulcerative Colitis With Depression | September 10, 2021 | August 31, 2022 |
| NCT02130349 | Unknown status | IBDSL Biobank Project. Molecular Markers for Diagnosis and Therapy Response in IBD. | February 2011 | December 2020 | |
| NCT01494857 | Unknown status | Phase 3 | Efficacy and Safety of Adalimumab for the Induction of Clinical Response in Ulcerative Colitis | January 2012 | December 2013 |
| NCT01479660 | Unknown status | Phase 4 | Role of Healthy Bacteria in Ulcerative Colitis | March 2011 | October 2014 |
| NCT02084550 | Unknown status | N/A | Amino Acids in Ileal Pouch-anal Anastomosis for Ulcerative Colitis | September 2015 | September 2017 |
| NCT02066272 | Unknown status | Safety of Anti-tumor Necrosis Factor (TNF) Monoclonal Antibodies in Inflammatory Bowel Disease | January 2014 | December 2016 | |
| NCT01914887 | Unknown status | Phase 1/Phase 2 | Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells for the Induction of Remission in Ulcerative Colitis | June 2013 | December 2013 |
| NCT01882205 | Unknown status | N/A | Comparison Between Chromoendoscopy and Virtual Chromoendoscopy (NBI, I-scan, FICE) for Detection of Neoplasia in Long Standing Ulcerative Colitis | May 2008 | |
| NCT05190484 | Unknown status | bIosimilar of aDalimumab, an European evAluation | April 30, 2022 | April 30, 2024 | |
| NCT01244386 | Unknown status | Low-dose CT Using Iterative Reconstruction in Patients With Inflammatory Bowel Disease | June 2010 | December 2011 | |
| NCT01221428 | Unknown status | Phase 1/Phase 2 | Umbilical Cord Mesenchymal Stem Cells Infusion for Ulcerative Colitis | September 2010 | December 2012 |
| NCT00745329 | Unknown status | The Effect of Infliximab on Sperm Quality | October 2008 | ||
| NCT01216280 | Unknown status | Phase 2 | Efficacy and Tolerability Study of Natura-Alpha in the Treatment of Patients With Active Ulcerative Colitis | July 2010 | September 2011 |
| NCT00309660 | Unknown status | Phase 1/Phase 2 | Treatment With Local PPARgamma Ligand in Distal Ulcerative Colitis | November 2005 | June 2007 |
| NCT01171807 | Unknown status | Phase 2 | Erythrocytes-Mediated Delivery Of Dexamethasone 21-Phosphate In Steroid-Dependent Ulcerative Colitis | April 2003 | December 2011 |
| NCT05321485 | Unknown status | N/A | The Effect of MedicijnWijs on Adherence to Azathioprine Therapy in Adolescents With IBD | March 16, 2022 | September 16, 2022 |
| NCT05336773 | Unknown status | Ulcerative Colitis Mayo Score With Artificial Intelligence | April 2022 | June 2023 | |
| NCT05350644 | Unknown status | Inflammatory Bowel Disease(IBD), Treatment Response | February 8, 2022 | January 14, 2024 | |
| NCT05386290 | Unknown status | A Multicentered Prospective Cohort Study of Chinese IBD Patients | July 9, 2020 | December 2023 | |
| NCT05404074 | Unknown status | Phase 1 | Pharmacokinetics of Cobitolimod Enemas in Participants With Active Ulcerative Colitis | November 22, 2021 | October 30, 2022 |
| NCT05427942 | Unknown status | Yuflyma® (Adalimumab), Patient Experience After Switching | June 3, 2022 | March 1, 2023 | |
| NCT05431283 | Unknown status | Real-world Effectiveness of Tofacitinib on Ulcerative Colitis Associated Spondyloarthropathy | April 25, 2022 | December 31, 2023 | |
| NCT01111708 | Unknown status | N/A | Clinical Outcome After Close Rectal Ileo Pouch Anal Anastomosis for Colitis Ulcerosa(CU) | April 2010 | April 2013 |
| NCT01078935 | Unknown status | Phase 4 | The Effect of Probiotics on the Rate of Recovery of Inflammatory Bowel Disease Exacerbation, Endothelial Function, and Markers of Inflammation | December 2012 | |
| NCT01783119 | Unknown status | Early Phase 1 | Effect of Aloe Vera in the Inflammation of Patients With Mild Ulcerative Colitis | August 2012 | December 2014 |
| NCT01771224 | Unknown status | Early Phase 1 | Effect of FAn-7 in UC Activity | January 2013 | December 2014 |
| NCT03729674 | Unknown status | Comparative Effectiveness and Safety of Biosimilar and Legacy Drugs | November 26, 2018 | December 31, 2022 | |
| NCT03698500 | Unknown status | N/A | Specific microRNAs as Potential Biomarker for Inflammatory Bowel Disease | January 2017 | December 2020 |
| NCT03648398 | Unknown status | N/A | Pilot Study of an Online Therapeutic Education Program for Patients With Inflammatory Bowel Disease | January 29, 2021 | April 1, 2023 |
| NCT03640637 | Unknown status | The Role of PET/MRI in the Diagnosis and Treatment of Children and Adolescents With Inflammatory Bowel Diseases | October 18, 2018 | August 2021 | |
| NCT03594708 | Unknown status | N/A | Immunonutrition in Ulcerative Colitis | April 30, 2018 | December 31, 2018 |
| NCT01040910 | Unknown status | Phase 1/Phase 2 | Cannabis for Inflammatory Bowel Disease | January 2010 | July 2012 |
| NCT01752361 | Unknown status | Gastrointestinal Transit Times and Motility in Severe Ulcerative Colitis Obtained by Motilis-3D-transit | April 2013 | March 2015 | |
| NCT01745029 | Unknown status | Gastrointestinal Motility in Severe Ulcerative Colitis Obtained by Motilis-3D-transit | April 2013 | March 2015 | |
| NCT03582969 | Unknown status | Phase 2 | Capsulized Fecal Microbiota Transplantation in Pediatric Ulcerative Colitis Patients | August 2018 | July 2022 |
| NCT03581149 | Unknown status | Phase 4 | Tolerability and Efficacy of Sodium Picosulfate/Magnesium Citrate Versus PEG/Ascorbic Acid in Ulcerative Colitis Patients | March 26, 2018 | July 26, 2020 |
| NCT03561532 | Unknown status | N/A | Fecal Transplantation in Ulcerative Colitis | October 1, 2016 | May 31, 2020 |
| NCT03536988 | Unknown status | N/A | TAMIS-IPAA vs. Lap-IPAA for Ulcerative Colitiis | April 12, 2018 | December 1, 2020 |
| NCT03839680 | Unknown status | Measuring Endoscopic ACTIvity in Patients Treated With VEDOlizumab for Ulcerative Colitis | February 1, 2018 | April 15, 2019 | |
| NCT00292175 | Unknown status | N/A | NBI With Magnification for Dysplasia Detection in Ulcerative Colitis | February 2006 | |
| NCT03504930 | Unknown status | COLISURG : Exploratory Analysis of Sexual Function and the Impact of Biotherapies on Postoperative Morbidity. | June 7, 2018 | December 7, 2022 | |
| NCT03477032 | Unknown status | FMT in Inflammatory Bowel Disease | June 1, 2018 | December 31, 2019 | |
| NCT03863886 | Unknown status | N/A | Endoscopic Ultrasound Determines Disease Activity in Crohn's Disease And Ulcerative Colitis | January 4, 2019 | June 2022 |
| NCT03872726 | Unknown status | Development and Validation of a Self-reported Objective Index of Work Disability in Inflammatory Bowel Disease | March 1, 2019 | May 30, 2019 | |
| NCT01011322 | Unknown status | Phase 2 | A Study to Investigate the Efficacy of LT-02 in Patients With Mesalazine Refractory Ulcerative Colitis | December 2009 | February 2012 |
| NCT03394586 | Unknown status | Real-world Data Regarding Treatment of Ulcerative Colitis Patients With Golimumab | January 1, 2018 | December 31, 2018 | |
| NCT03941418 | Unknown status | N/A | Impact of Additional Treatment With Saccharomyces Boulardii on Quality of Life in Patients With Mild Forms of Ulcerative Colitis and Crohn Disease | June 1, 2019 | March 31, 2020 |
| NCT03942861 | Unknown status | Sonographic Assessment in Severe Ulcerative Colitis Patients Admitted for Intravenous Corticosteroids and Eligible for Infliximab Rescue Therapy; a Prospective Clinician-blinded Observational Study Protocol. | February 21, 2019 | February 21, 2022 | |
| NCT01010815 | Unknown status | Metagenomic Analysis of Gut Microbiome in Korean Patients With Ulcerative Colitis | November 2009 | November 2011 | |
| NCT03368118 | Unknown status | Phase 2 | Study Evaluating the Long-term Safety and Efficacy of ABX464 in Active Ulcerative Colitis | January 20, 2018 | October 2022 |
| NCT03366090 | Unknown status | Immunological Profiles in Inflammatory Bowel Disease | October 1, 2017 | July 1, 2020 | |
| NCT03949257 | Unknown status | N/A | Dynamic Changes of Gut Microbiota in UC After FMT | June 1, 2019 | December 1, 2019 |
| NCT03952364 | Unknown status | The PRECIOUS Study: Predicting Crohn's & ColitIs Outcomes in the United States | October 10, 2019 | June 2022 | |
| NCT03955328 | Unknown status | N/A | Progression of Damage in Ulcerative Colitis | June 15, 2019 | June 15, 2020 |
| NCT03973437 | Unknown status | N/A | Development and Validation of a Deep Learning Algorithm to Evaluate Endoscopic Disease Activity of Ulcerative Colitis. | June 1, 2019 | June 1, 2020 |
| NCT03327038 | Unknown status | N/A | Addressing Depression and Anxiety Symptoms in Patients With Inflammatory Bowel Disease | January 1, 2018 | January 1, 2020 |
| NCT03324334 | Unknown status | Prevalence of Graves Disease in Patients With Ulcerative Colitis | November 1, 2017 | February 28, 2019 | |
| NCT04006080 | Unknown status | Phase 4 | Investigation of the Faecal Loss of Vedolizumab and Its Role in Influencing Serum Drug Levels, Outcomes and Response in Ulcerative Colitis | July 1, 2019 | March 2020 |
| NCT04006977 | Unknown status | N/A | Multistrain Probiotics Reduces UC Depression and Anxiety Scores | October 2019 | May 2020 |
| NCT04011943 | Unknown status | N/A | Fecal Microbiota Transplantation for Health Improvement (TFM3) | May 21, 2018 | December 1, 2020 |
| NCT03273465 | Unknown status | Phase 2 | Fecal Microbiota Transplantation in Ulcerative Colitis | March 27, 2017 | April 2021 |
| NCT04023396 | Unknown status | Phase 2 | Efficacy and Safety Study of ABX464 as Maintenance Therapy in Patients With Moderate to Severe Ulcerative Colitis | January 13, 2020 | March 2023 |
| NCT04029649 | Unknown status | Phase 2/Phase 3 | Beta-1,3/1,6-D-Glucan Ganoderma Lucidum on Ulcerative Colitis | August 2019 | December 2020 |
| NCT04031482 | Unknown status | TARGET Registry A Project of the German Network for Intestinal Diseases in Cooperation With Other Corporate Partners | October 2019 | September 2023 | |
| NCT04034758 | Unknown status | N/A | Safety and Efficacy of Heterologous FMT by SQIMC-md Capsule in Mild-moderate Ulcerative Colitis Patients | August 30, 2019 | December 31, 2023 |
| NCT04057547 | Unknown status | Early Phase 1 | Efficacy and Safety of Modified Gegen Qinlian Decoction for Ulcerative Colitis With Damp-heat Syndrome | April 1, 2019 | December 31, 2023 |
| NCT04079335 | Unknown status | A Prospective Longitudinal Study of Fecal Microbiome and Calprotectin to Predict Relapse in Patients With IBD | January 28, 2019 | January 28, 2021 | |
| NCT04109300 | Unknown status | N/A | Preemptive HLA Genotyping for the Safe Use of Infliximab-combination Therapy in Inflammatory Bowel Disease | September 1, 2020 | September 1, 2023 |
| NCT04114292 | Unknown status | Phase 1 | TUDCA as a Therapy for Ulcerative Colitis (UC) | January 17, 2019 | July 31, 2022 |
| NCT04131530 | Unknown status | Automatic Evaluation of Inflammation Activity in Ulcerative Colitis Using pCLE With Artificial Intelligence | October 2019 | December 2019 | |
| NCT03257345 | Unknown status | VEST: The UK Vedolizumab Real Life Experience Study in Inflammatory Bowel Disease | February 3, 2017 | December 31, 2019 | |
| NCT04148274 | Unknown status | A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Ulcerative Colitis | March 2, 2020 | July 2023 | |
| NCT03239704 | Unknown status | N/A | Improving Outcomes Among Urgent Care Clinic Patients With Inflammatory Bowel Disease | December 1, 2018 | December 1, 2020 |
| NCT04156984 | Unknown status | Phase 4 | Comparison of Two Different Golimumab Dosing Regimens for Ulcerative Colitis | May 2020 | November 2022 |
| NCT04165265 | Unknown status | N/A | The Use of Web-app Constant-Care in Patients With Acute Severe Ulcerative Colitis Treated With Rescue Therapy | December 3, 2019 | December 31, 2021 |
| NCT01705522 | Unknown status | Multimodal Approach in IBD Patients | October 2012 | October 2019 | |
| NCT04189692 | Unknown status | Evolution of Fatigue in Patients With Inflammatory Bowel Disease | January 7, 2020 | December 7, 2020 | |
| NCT04197973 | Unknown status | Association Between Self-reported Web-based SCCAI and Health-related Quality of Life Index in UC Patients | December 18, 2019 | December 30, 2020 | |
| NCT03151850 | Unknown status | The Diversity of the Fungal and Bacterial in Colon Mucosa of Patients With Different Degree of Inflammation of Ulcerative Colitis | July 2016 | August 2017 | |
| NCT03136419 | Unknown status | N/A | Microbiota and Immune microEnvironment in Pouchitis | October 31, 2016 | April 30, 2019 |
| NCT03131414 | Unknown status | The IMAGINE-SPOR CIHR Chronic Disease Network | October 1, 2017 | June 1, 2023 | |
| NCT03110289 | Unknown status | N/A | Restoration of the Microbiome Through Superdonor Selection | April 30, 2017 | April 30, 2019 |
| NCT03091309 | Unknown status | N/A | Counseling to Optimize Adherence in Expectant Mothers With Inflammatory Bowel Disease | October 1, 2017 | October 1, 2020 |
| NCT04257084 | Unknown status | N/A | Surveillance in Ulcerative Colitis: Narrow Band Image Versus Chromoendoscopy for High-risk Groups | December 2020 | January 2023 |
| NCT03016780 | Unknown status | Phase 1/Phase 2 | Fecal Microbiota Transplantation for Ulcerative Colitis | July 2016 | July 2019 |
| NCT01697670 | Unknown status | Phase 1 | Photodynamic Therapy for Ulcerative Colitis | September 2012 | December 2012 |
| NCT04309058 | Unknown status | Early Phase 1 | Observation of the Effect of Vitamin D Supplementation on Chronic Course of Patients With Ulcerative Colitis Based on Vitamin D Receptor Fok I Gene Polymorphism | March 2020 | March 2021 |
| NCT04329481 | Unknown status | N/A | The Effect of Mycobiome Supplementation on Gastrointestinal Symptoms in IBD Patients | June 12, 2018 | June 12, 2024 |
| NCT02683733 | Unknown status | Phase 3 | Bio-enhanced Curcumin as an Add-On Treatment in Mild to Moderate Ulcerative Colitis | February 2016 | |
| NCT04398550 | Unknown status | N/A | SCD vs. Mediterranean Diet Therapy in Ulcerative Colitis | September 3, 2020 | December 31, 2023 |
| NCT04408703 | Unknown status | PRognOstiC valuE of rEd Density in Ulcerative Colitis | June 2020 | June 2022 | |
| NCT02914717 | Unknown status | The Belgian SMART Study Evaluating the Use of Golimumab for Ulcerative Colitis | September 2016 | May 2018 | |
| NCT02910375 | Unknown status | Phase 4 | Golimumab Dried Blood Spot Analysis | December 2016 | May 2018 |
| NCT02852850 | Unknown status | In Vivo Molecular Imaging Predicts Therapeutic Response in Ulcerative Colitis | January 2016 | ||
| NCT04543994 | Unknown status | Phase 1/Phase 2 | Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Ulcerative Colitis (UC) | November 10, 2020 | November 2023 |
| NCT02772406 | Unknown status | N/A | Linked Color Imaging vs. White Light for Colorectal Dysplasia in Ulcerative Colitis | April 2016 | December 2016 |
| NCT02768974 | Unknown status | Phase 2 | Open Label Study to Assess Safety, PK and Explore Efficacy of OPRX-106 in Patients With Active Mild to Moderate Ulcerative Colitis | September 2016 | |
| NCT00510978 | Unknown status | Phase 2/Phase 3 | Probiotics in GastroIntestinal Disorders | January 2002 | November 2007 |
| NCT02721823 | Unknown status | N/A | Randomized Controlled Trial of Stress Reduction and Lifestyle Modification for Ulcerative Colitis | March 2016 | October 2019 |
| NCT02683759 | Unknown status | Phase 3 | Bio-enhanced Curcumin as an Add-on Treatment in Maintaining Remission of Ulcerative Colitis | February 2016 | |
| NCT04653259 | Unknown status | N/A | Digital Nutrition Therapy for Patients With IBD | May 15, 2021 | October 15, 2022 |
| NCT04659148 | Unknown status | Surgical and Oncological Outcomes in Patients With Ulcerative Colitis-associated Rectal Cancer | October 1, 2020 | April 1, 2021 | |
| NCT00883077 | Unknown status | Assessment of Colonic Permeability by Confocal Laser Endomicroscopy | April 2009 | December 2009 | |
| NCT02277223 | Withdrawn | Phase 3 | Curcumin in Pediatric Ulcerative Colitis | March 1, 2020 | December 31, 2022 |
| NCT02962245 | Withdrawn | Phase 4 | Efficacy of Treatment With Berberine to Maintain Remission in Ulcerative Colitis | November 2016 | January 2018 |
| NCT01524120 | Withdrawn | Endoscopy and Endomicroscopy for Assessment of Mucosal Healing in Inflammatory Bowel Disease (IBD) | April 2012 | ||
| NCT01846026 | Withdrawn | Phase 1/Phase 2 | Ulcerative Colitis and Vitamin D Supplementation | April 2013 | December 2016 |
| NCT00815061 | Withdrawn | Epidemiology of Ulcerative Colitis and Crohn's Disease in Non Jewish Israel Population | July 2008 | December 2016 | |
| NCT01640496 | Withdrawn | N/A | Vitamin D Treatment in Ulcerative Colitis | July 2012 | December 2014 |
| NCT00783575 | Withdrawn | Genetic Markers as Predictors of Phenotypes in Pediatric Onset Crohn's Disease | October 2002 | January 2015 | |
| NCT01293656 | Withdrawn | Study of Participants With Crohn's Disease and Ulcerative Colitis in Eastern Europe, Middle East, and North Africa (P08166) | August 2011 | July 2012 | |
| NCT01434576 | Withdrawn | Phase 1 | Study to Evaluate the Pharmacodynamics and Safety of HGS1025 in Patients With Ulcerative Colitis | December 2011 | |
| NCT04469062 | Withdrawn | Phase 3 | A Study of Mirikizumab (LY3074828) in Participants With Ulcerative Colitis | April 20, 2021 | June 5, 2024 |
| NCT03237260 | Withdrawn | Phase 4 | An Open Label Single-arm Phase 4 Study of Vedolizumab in Subjects With Newly Diagnosed Active Ulcerative Colitis | July 1, 2017 | February 1, 2019 |
| NCT04156672 | Withdrawn | Real World Study Of The Clinical Profile And Treatment Outcomes Of Advanced Therapies For Ulcerative Colitis In Portugal | October 6, 2020 | April 30, 2021 | |
| NCT05652491 | Withdrawn | The Role of Gut Microbiome in Predicting Comorbidities and Complications in Children With Inflammatory Bowel Disease | December 9, 2022 | May 30, 2023 | |
| NCT00213330 | Withdrawn | Cerebral Resonance Magnetic Imaging During Rectal Distention | April 2003 | February 2006 | |
| NCT04202211 | Withdrawn | Phase 2 | FMT for Remission of Active Ulcerative Colitis in Adults | March 2022 | December 2028 |
| NCT05121402 | Withdrawn | Phase 2 | Safety and Efficacy Study of TLL018 in the Treatment of Ulcerative Colitis | December 30, 2022 | December 30, 2023 |
| NCT04209556 | Withdrawn | Phase 2 | A Study To Evaluate The Safety And Efficacy Of PF-06826647 In Participants With Moderate To Severe Ulcerative Colitis | September 30, 2020 | October 26, 2023 |
| NCT02913508 | Withdrawn | Phase 2 | Vedolizumab Subcutaneous (SC) Versus Intravenous (IV) in Ulcerative Colitis or Crohn's Disease | April 2014 | December 2015 |
| NCT04096573 | Withdrawn | Phase 2 | Efficacy and Safety of LC51-0255 in Subjects With Ulcerative Colitis | April 2020 | August 2022 |
| NCT04898348 | Withdrawn | Phase 2 | A Study to Investigate Efficacy and Safety of KBL697 in Patients With Mild to Moderate Active Ulcerative Colitis | January 14, 2022 | July 28, 2023 |
| NCT03309865 | Withdrawn | Early Phase 1 | Evaluating the Combined Effect of Vedolizumab and Semi-Vegetarian Diet on Ulcerative Colitis. | December 25, 2017 | December 31, 2018 |
| NCT03953794 | Withdrawn | Inflammatory Bowel Disease Tracker (IBD Tracker) | October 2019 | February 2021 | |
| NCT01961492 | Withdrawn | N/A | Fecal Microbiota Transplantation in Patients With Ulcerative Colitis | October 2013 | December 2018 |
| NCT05104229 | Withdrawn | Phase 3 | SAVES-IBD: Safety & Efficacy of Aspirin vs. Standard of Care for VTE Prophylaxis After IBD Surgery | June 1, 2024 | January 1, 2026 |
| NCT02144129 | Withdrawn | N/A | Effects of WB-EMS in Ulcerative Colitis Patients | March 2014 | January 2018 |
| NCT04259060 | Withdrawn | Phase 2 | Hydroxocobalamin Approach for Reducing of Calprotectin With Butyrate for Ulcerative Colitis Remission | January 2024 | October 2025 |
| NCT03059849 | Withdrawn | Phase 4 | Brief Escalation of Adalimumab Treatment for Prevention of Clinical Relapse in IBD | February 1, 2018 | September 1, 2019 |
| NCT00578799 | Withdrawn | Phase 1 | Effects of Probiotics in Patients With Ulcerative Colitis | December 2007 | December 2007 |
| NCT00895336 | Withdrawn | Phase 2 | Lactobacillus GG in Pediatric Ulcerative Colitis (UC) | March 2011 | October 2012 |
| NCT02729233 | Withdrawn | N/A | Predicting Clinical Response to Golimumab With Mucosal Barrier Dysfunction | January 2017 | January 27, 2017 |
| NCT00259571 | Withdrawn | Phase 2/Phase 3 | Retarded Phosphatidylcholine Versus Mesalazin in Remission of Ulcerative Colitis. | March 2010 | |
| NCT03808506 | Withdrawn | Relationship Between Baseline Burden of Disease and TDM in Ulcerative Colitis | September 1, 2019 | July 19, 2022 | |
| NCT01787786 | Withdrawn | Improving Treatment of Inflammatory Bowel Diseases Through Better Understanding Infliximab Drug and Antibody Levels | September 2017 | ||
| NCT02201758 | Withdrawn | N/A | Flaxseed Lignan-Enriched Complex (FLC) for the Treatment of Patients With Ulcerative Colitis (UC): A Pilot Assessment | December 2018 | December 2019 |
| NCT01810185 | Withdrawn | Phase 2 | Low Dose Naltrexone in Symptomatic Inflammatory Bowel Disease | March 2013 | March 2014 |
| NCT05246943 | Withdrawn | The Correlation of a D-dimer Testing Protocol With Venous Thromboembolism in Surgical Colorectal Patients | May 25, 2022 | November 4, 2022 |
- Disase is a (Disease Ontology)
- DOID:0060180
- Cross Reference ID (Disease Ontology)
- EFO:0000729
- Cross Reference ID (Disease Ontology)
- ICD10CM:K51
- Cross Reference ID (Disease Ontology)
- ICD9CM:556
- Cross Reference ID (Disease Ontology)
- ICD9CM:556.5
- Cross Reference ID (Disease Ontology)
- MESH:D003093
- Cross Reference ID (Disease Ontology)
- NCI:C2952
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:196988003
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:441971007
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0009324
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0375359
- Exact Synonym (Disease Ontology)
- Left-sided ulcerative colitis
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0100279
- ICD10 preferred id (Insert disease from ICD10)
- D0008721
- ICD10 class code (Insert disease from ICD10)
- K51